export type Language = 'en' | 'de' | 'fr' | 'es' | 'zh' | 'ar';

export const languages: { code: Language; name: string; flag: string; rtl?: boolean }[] = [
  { code: 'en', name: 'English', flag: 'ğŸ‡¬ğŸ‡§' },
  { code: 'de', name: 'Deutsch', flag: 'ğŸ‡©ğŸ‡ª' },
  { code: 'fr', name: 'FranÃ§ais', flag: 'ğŸ‡«ğŸ‡·' },
  { code: 'es', name: 'EspaÃ±ol', flag: 'ğŸ‡ªğŸ‡¸' },
  { code: 'zh', name: 'ä¸­æ–‡', flag: 'ğŸ‡¨ğŸ‡³' },
  { code: 'ar', name: 'Ø§Ù„Ø¹Ø±Ø¨ÙŠØ©', flag: 'ğŸ‡¸ğŸ‡¦', rtl: true },
];

export const translations = {
  en: {
    nav: {
      services: 'Services',
      insights: 'Insights',
      about: 'About',
      contact: 'Contact',
    },
    hero: {
      tagline: 'EMEA Healthcare Market Research',
      title: 'EMEA Healthcare Market Research for Pharmaceutical Excellence',
      subtitle: 'Transform Physician & Hospital Insights into Strategic Intelligence Across UK, Europe & MENA Markets',
      valueProposition: 'We deliver comprehensive quantitative and qualitative market research services that transform clinical data into actionable pharmaceutical intelligence. Our specialized methodology captures authentic physician perspectives from NHS and private healthcare settings, hospital trends, and patient insights across UK, European, and MENA markets to power your drug development, market access, and commercial strategies.',
      serviceHighlights: [
        'UK NHS & Private Healthcare Research',
        'Pan-European Physician Surveys',
        'Qualitative KOL Interviews',
        'Multi-Country Data Analytics',
        'UK â€¢ Europe â€¢ MENA Coverage',
      ],
      cta: 'Get UK Research Proposal',
      ctaSecondary: 'View European Case Studies',
      trustBar: 'Trusted by pharmaceutical companies in',
      trustCountries: 'UK â€¢ Germany â€¢ France â€¢ Spain â€¢ Italy â€¢ UAE â€¢ Saudi Arabia â€¢ Egypt â€¢ Kuwait â€¢ Qatar',
      complianceBadges: ['MHRA Compliant', 'EMA Aligned', 'GDPR Compliant', 'SFDA Compliant', 'ICH-GCP'],
    },
    services: {
      title: 'Comprehensive Healthcare Market Research Services for UK & European Pharmaceutical Companies',
      subtitle: 'Quantitative and qualitative insights from physicians and hospitals across UK, Europe & MENA',
      items: [
        {
          title: 'Quantitative Healthcare Research & Physician Surveys Across UK & Europe',
          description: 'Robust statistical insights from large-scale physician and healthcare professional surveys across UK, European and MENA markets. NHS physician surveys and GP practice research, private healthcare provider studies (UK, Germany, France), hospital preference studies, prescription behavior tracking, NICE/HTA decision-maker insights, payer and reimbursement landscape analysis. Multi-country physician surveys (UAE, Saudi Arabia, Egypt, Kuwait, Qatar). Deliverables: Statistical reports, UK/EU market size estimates, NHS pathway analysis, trend forecasting, segmentation analysis, cross-country comparative insights.',
        },
        {
          title: 'Qualitative Pharmaceutical Research & Expert Insights - UK & Europe',
          description: 'Deep-dive qualitative research capturing nuanced clinical perspectives and unmet medical needs. UK: In-depth NHS consultant and GP interviews, private healthcare specialist insights, NICE committee member engagement, Royal College expert advisory boards. European: Pan-European KOL mapping and interviews, multi-country healthcare stakeholder focus groups, cross-border treatment pathway analysis. MENA: Regional physician and hospital administrator interviews, Gulf healthcare system insights. Deliverables: Thematic analysis reports, UK NHS insights, European consensus summaries, strategic market access recommendations.',
        },
        {
          title: 'Market Access & HTA Strategy',
          description: 'NICE, G-BA, HAS and HTA body requirement integration. Evidence-based pricing strategies and payer engagement frameworks for UK and European markets. Reimbursement landscape modeling and cost-effectiveness analysis for HTA submissions.',
        },
        {
          title: 'KOL & Stakeholder Mapping',
          description: 'UK and Pan-European KOL mapping and engagement. NHS consultant and Royal College member networks. Multi-country medical association partnerships and hospital provider panels.',
        },
        {
          title: 'Geographic Coverage: UK â€¢ Europe â€¢ MENA',
          description: 'UK: NHS England, Scotland, Wales, Northern Ireland; London teaching hospitals; NICE, MHRA stakeholder research. Europe: Germany (G-BA, IQWiG), France (HAS, CEPS), Spain, Italy, Netherlands, Belgium, Switzerland. MENA: UAE (DHA, HAAD), Saudi Arabia (Vision 2030), Egypt, Kuwait, Qatar.',
        },
        {
          title: 'Methodology & Compliance',
          description: 'MHRA and EMA regulatory alignment. GDPR-compliant data collection. NHS Research Ethics Committee (REC) standards. Multi-lingual survey deployment (English, German, French, Spanish, Italian, Arabic). Secure data encryption and HEOR analysis.',
        },
      ],
    },
    insights: {
      title: 'Latest Insights',
      subtitle: 'Thought leadership and research perspectives from our global team',
      readMore: 'Read Article',
      items: [
        {
          category: 'Market Access',
          title: 'The Future of Value-Based Healthcare Agreements in Europe',
          excerpt: 'How innovative contracting models are reshaping pharmaceutical pricing and access strategies across major European markets.',
          date: '2024 Q4 Report',
        },
        {
          category: 'Digital Health',
          title: 'AI-Driven Drug Discovery: Market Implications',
          excerpt: 'Analyzing the competitive landscape shift as artificial intelligence transforms pharmaceutical R&D and time-to-market.',
          date: 'Strategic Brief',
        },
        {
          category: 'Oncology',
          title: 'Precision Medicine Market Dynamics 2025',
          excerpt: 'Comprehensive analysis of biomarker-driven therapies and the evolving oncology treatment paradigm.',
          date: 'Industry Analysis',
        },
      ],
    },
    blog: {
      title: 'Latest Insights',
      subtitle: 'Thought leadership and research perspectives from our global team',
      readMore: 'Read Article',
      readMoreArticles: 'Read more articles',
      filterAllTopics: 'All topics',
      filterAllCountries: 'All countries',
      filterByTopic: 'Topic',
      filterByCountry: 'Country',
      items: [
        { category: 'Market Access', country: 'Europe', title: 'The Future of Value-Based Healthcare Agreements in Europe', excerpt: 'How innovative contracting models are reshaping pharmaceutical pricing and access strategies across major European markets.', date: '2024 Q4 Report' },
        { category: 'Digital Health', country: 'USA', title: 'AI-Driven Drug Discovery: Market Implications', excerpt: 'Analyzing the competitive landscape shift as artificial intelligence transforms pharmaceutical R&D and time-to-market.', date: 'Strategic Brief' },
        { category: 'Oncology', country: 'UK', title: 'Precision Medicine Market Dynamics 2025', excerpt: 'Comprehensive analysis of biomarker-driven therapies and the evolving oncology treatment paradigm.', date: 'Industry Analysis' },
      ],
    },
    stats: {
      title: 'Global Impact',
      items: [
        { value: '50+', label: 'Countries Covered' },
        { value: '10+', label: 'Pharma Clients' },
        { value: '120+', label: 'Projects Delivered' },
        { value: '15+', label: 'Years Experience' },
      ],
    },
    testimonials: {
      title: 'Client Perspectives',
      subtitle: 'Trusted by leading pharmaceutical and biotech companies worldwide',
    },
    contact: {
      title: "Let's Connect",
      subtitle: 'Ready to transform your healthcare market strategy? Our team of experts is here to help.',
      cta: 'Schedule a Consultation',
      email: 'admin@bionixus.com',
      headquarters: 'Wyoming, USA',
    },
    localePrompt: {
      title: 'You are opening from {region}.',
      question: 'Do you want to switch to {language}?',
      yes: 'Yes',
      no: 'No',
    },
    footer: {
      tagline: 'EMEA Healthcare Market Research | Pharma Insights Europe & MENA',
      copyright: 'Â© 2024 BioNixus. All rights reserved.',
      privacy: 'Privacy Policy',
      terms: 'Terms of Service',
    },
    cookieConsent: {
      message: 'We use cookies to improve your experience and analyse site traffic. By clicking Accept you agree to our use of cookies and our Privacy Policy.',
      accept: 'Accept',
      decline: 'Decline',
      privacyLink: 'Privacy Policy',
    },
  },
  de: {
    nav: {
      services: 'Leistungen',
      insights: 'Erkenntnisse',
      about: 'Ãœber uns',
      contact: 'Kontakt',
    },
    hero: {
      tagline: 'EMEA Healthcare Market Research',
      title: 'EMEA Healthcare Market Research for Pharmaceutical Excellence',
      subtitle: 'Transform Physician & Hospital Insights into Strategic Intelligence Across UK, Europe & MENA Markets',
      valueProposition: 'We deliver comprehensive quantitative and qualitative market research services that transform clinical data into actionable pharmaceutical intelligence. Our specialized methodology captures authentic physician perspectives from NHS and private healthcare settings, hospital trends, and patient insights across UK, European, and MENA markets to power your drug development, market access, and commercial strategies.',
      serviceHighlights: ['UK NHS & Private Healthcare Research', 'Pan-European Physician Surveys', 'Qualitative KOL Interviews', 'Multi-Country Data Analytics', 'UK â€¢ Europe â€¢ MENA Coverage'],
      cta: 'Get UK Research Proposal',
      ctaSecondary: 'View European Case Studies',
      trustBar: 'Trusted by pharmaceutical companies in',
      trustCountries: 'UK â€¢ Germany â€¢ France â€¢ Spain â€¢ Italy â€¢ UAE â€¢ Saudi Arabia â€¢ Egypt â€¢ Kuwait â€¢ Qatar',
      complianceBadges: ['MHRA Compliant', 'EMA Aligned', 'GDPR Compliant', 'SFDA Compliant', 'ICH-GCP'],
    },
    services: {
      title: 'Unsere Expertise',
      subtitle: 'Umfassende GesundheitsmarktforschungslÃ¶sungen, zugeschnitten auf Ihre strategischen BedÃ¼rfnisse',
      items: [
        {
          title: 'Marktzugang & Preisgestaltung',
          description: 'Navigieren Sie komplexe Erstattungslandschaften mit evidenzbasierten Preisstrategien und KostentrÃ¤ger-Engagement-Frameworks.',
        },
        {
          title: 'Wettbewerbsanalyse',
          description: 'Bleiben Sie mit Echtzeit-Wettbewerbsbeobachtung, Pipeline-Analyse und strategischen Positionierungserkenntnissen voraus.',
        },
        {
          title: 'Patientenreise-Mapping',
          description: 'Verstehen Sie die gesamte Patientenerfahrung von der Diagnose bis zur Behandlung, um BerÃ¼hrungspunkte und Ergebnisse zu optimieren.',
        },
        {
          title: 'KOL & Stakeholder-Analyse',
          description: 'Identifizieren und engagieren Sie Key Opinion Leader mit datengestÃ¼tztem Einfluss-Mapping und Beziehungsstrategien.',
        },
        {
          title: 'Klinische Studienoptimierung',
          description: 'Beschleunigen Sie die Entwicklung mit Standortauswahl-Analytik, Patientenrekrutierungsstrategien und Protokolloptimierung.',
        },
        {
          title: 'Launch-Exzellenz',
          description: 'Maximieren Sie die Launch-Wirkung mit integrierten Go-to-Market-Strategien, Prognosen und Marktgestaltungsinitiativen.',
        },
      ],
    },
    insights: {
      title: 'Aktuelle Erkenntnisse',
      subtitle: 'Thought Leadership und Forschungsperspektiven von unserem globalen Team',
      readMore: 'Artikel lesen',
      items: [
        {
          category: 'Marktzugang',
          title: 'Die Zukunft wertbasierter Gesundheitsvereinbarungen in Europa',
          excerpt: 'Wie innovative Vertragsmodelle pharmazeutische Preis- und Zugangsstrategien in groÃŸen europÃ¤ischen MÃ¤rkten umgestalten.',
          date: '2024 Q4 Bericht',
        },
        {
          category: 'Digitale Gesundheit',
          title: 'KI-gesteuerte Arzneimittelentdeckung: Marktimplikationen',
          excerpt: 'Analyse der Wettbewerbslandschaftsverschiebung, wÃ¤hrend kÃ¼nstliche Intelligenz pharmazeutische F&E transformiert.',
          date: 'Strategische Kurzanalyse',
        },
        {
          category: 'Onkologie',
          title: 'PrÃ¤zisionsmedizin Marktdynamik 2025',
          excerpt: 'Umfassende Analyse von Biomarker-gesteuerten Therapien und dem sich entwickelnden Onkologie-Behandlungsparadigma.',
          date: 'Branchenanalyse',
        },
      ],
    },
    blog: {
      title: 'Aktuelle Erkenntnisse',
      subtitle: 'Thought Leadership und Forschungsperspektiven von unserem globalen Team',
      readMore: 'Artikel lesen',
      readMoreArticles: 'Weitere Artikel lesen',
      filterAllTopics: 'Alle Themen',
      filterAllCountries: 'Alle LÃ¤nder',
      filterByTopic: 'Thema',
      filterByCountry: 'Land',
      items: [
        { category: 'Marktzugang', country: 'Europa', title: 'Die Zukunft wertbasierter Gesundheitsvereinbarungen in Europa', excerpt: 'Wie innovative Vertragsmodelle pharmazeutische Preis- und Zugangsstrategien in groÃŸen europÃ¤ischen MÃ¤rkten umgestalten.', date: '2024 Q4 Bericht' },
        { category: 'Digitale Gesundheit', country: 'USA', title: 'KI-gesteuerte Arzneimittelentdeckung: Marktimplikationen', excerpt: 'Analyse der Wettbewerbslandschaftsverschiebung, wÃ¤hrend kÃ¼nstliche Intelligenz pharmazeutische F&E transformiert.', date: 'Strategische Kurzanalyse' },
        { category: 'Onkologie', country: 'UK', title: 'PrÃ¤zisionsmedizin Marktdynamik 2025', excerpt: 'Umfassende Analyse von Biomarker-gesteuerten Therapien und dem sich entwickelnden Onkologie-Behandlungsparadigma.', date: 'Branchenanalyse' },
      ],
    },
    stats: {
      title: 'Globale Wirkung',
      items: [
        { value: '50+', label: 'Abgedeckte LÃ¤nder' },
        { value: '10+', label: 'Pharma-Kunden' },
        { value: '120+', label: 'Gelieferte Projekte' },
        { value: '15+', label: 'Jahre Erfahrung' },
      ],
    },
    testimonials: {
      title: 'Kundenperspektiven',
      subtitle: 'Vertraut von fÃ¼hrenden Pharma- und Biotech-Unternehmen weltweit',
    },
    contact: {
      title: 'Kontaktieren Sie uns',
      subtitle: 'Bereit, Ihre Gesundheitsmarktstrategie zu transformieren? Unser Expertenteam steht Ihnen zur VerfÃ¼gung.',
      cta: 'Beratung vereinbaren',
      email: 'admin@bionixus.com',
      headquarters: 'Wyoming, USA',
    },
    localePrompt: {
      title: 'Sie Ã¶ffnen von {region}.',
      question: 'MÃ¶chten Sie zu {language} wechseln?',
      yes: 'Ja',
      no: 'Nein',
    },
    footer: {
      tagline: 'Strategische Gesundheitsintelligenz',
      copyright: 'Â© 2024 BioNixus. Alle Rechte vorbehalten.',
      privacy: 'Datenschutz',
      terms: 'Nutzungsbedingungen',
    },
    cookieConsent: {
      message: 'Wir verwenden Cookies, um Ihre Erfahrung zu verbessern und den Website-Traffic zu analysieren. Mit Klick auf Akzeptieren stimmen Sie unserer Cookie-Nutzung und der DatenschutzerklÃ¤rung zu.',
      accept: 'Akzeptieren',
      decline: 'Ablehnen',
      privacyLink: 'Datenschutz',
    },
  },
  fr: {
    nav: {
      services: 'Services',
      insights: 'Perspectives',
      about: 'Ã€ propos',
      contact: 'Contact',
    },
    hero: {
      tagline: 'EMEA Healthcare Market Research',
      title: 'EMEA Healthcare Market Research for Pharmaceutical Excellence',
      subtitle: 'Transform Physician & Hospital Insights into Strategic Intelligence Across UK, Europe & MENA Markets',
      valueProposition: 'We deliver comprehensive quantitative and qualitative market research services that transform clinical data into actionable pharmaceutical intelligence. Our specialized methodology captures authentic physician perspectives from NHS and private healthcare settings, hospital trends, and patient insights across UK, European, and MENA markets to power your drug development, market access, and commercial strategies.',
      serviceHighlights: ['UK NHS & Private Healthcare Research', 'Pan-European Physician Surveys', 'Qualitative KOL Interviews', 'Multi-Country Data Analytics', 'UK â€¢ Europe â€¢ MENA Coverage'],
      cta: 'Get UK Research Proposal',
      ctaSecondary: 'View European Case Studies',
      trustBar: 'Trusted by pharmaceutical companies in',
      trustCountries: 'UK â€¢ Germany â€¢ France â€¢ Spain â€¢ Italy â€¢ UAE â€¢ Saudi Arabia â€¢ Egypt â€¢ Kuwait â€¢ Qatar',
      complianceBadges: ['MHRA Compliant', 'EMA Aligned', 'GDPR Compliant', 'SFDA Compliant', 'ICH-GCP'],
    },
    services: {
      title: 'Notre Expertise',
      subtitle: 'Solutions complÃ¨tes d\'Ã©tudes de marchÃ© santÃ© adaptÃ©es Ã  vos besoins stratÃ©giques',
      items: [
        {
          title: 'AccÃ¨s au MarchÃ© & Tarification',
          description: 'Naviguez dans des paysages de remboursement complexes avec des stratÃ©gies de prix basÃ©es sur les preuves.',
        },
        {
          title: 'Veille Concurrentielle',
          description: 'Gardez une longueur d\'avance avec une surveillance concurrentielle en temps rÃ©el et une analyse de pipeline.',
        },
        {
          title: 'Cartographie du Parcours Patient',
          description: 'Comprenez l\'expÃ©rience patient complÃ¨te du diagnostic au traitement pour optimiser les rÃ©sultats.',
        },
        {
          title: 'Analyse KOL & Parties Prenantes',
          description: 'Identifiez et engagez les leaders d\'opinion clÃ©s avec une cartographie d\'influence basÃ©e sur les donnÃ©es.',
        },
        {
          title: 'Optimisation des Essais Cliniques',
          description: 'AccÃ©lÃ©rez le dÃ©veloppement avec des analyses de sÃ©lection de sites et des stratÃ©gies de recrutement.',
        },
        {
          title: 'Excellence de Lancement',
          description: 'Maximisez l\'impact du lancement avec des stratÃ©gies go-to-market intÃ©grÃ©es et des prÃ©visions.',
        },
      ],
    },
    insights: {
      title: 'DerniÃ¨res Perspectives',
      subtitle: 'Leadership Ã©clairÃ© et perspectives de recherche de notre Ã©quipe mondiale',
      readMore: 'Lire l\'article',
      items: [
        {
          category: 'AccÃ¨s au MarchÃ©',
          title: 'L\'Avenir des Accords de SantÃ© BasÃ©s sur la Valeur en Europe',
          excerpt: 'Comment les modÃ¨les contractuels innovants remodÃ¨lent les stratÃ©gies de prix et d\'accÃ¨s pharmaceutiques.',
          date: 'Rapport T4 2024',
        },
        {
          category: 'SantÃ© NumÃ©rique',
          title: 'DÃ©couverte de MÃ©dicaments par l\'IA: Implications MarchÃ©',
          excerpt: 'Analyse du changement de paysage concurrentiel alors que l\'IA transforme la R&D pharmaceutique.',
          date: 'Note StratÃ©gique',
        },
        {
          category: 'Oncologie',
          title: 'Dynamique du MarchÃ© de la MÃ©decine de PrÃ©cision 2025',
          excerpt: 'Analyse complÃ¨te des thÃ©rapies guidÃ©es par biomarqueurs et du paradigme de traitement oncologique.',
          date: 'Analyse Sectorielle',
        },
      ],
    },
    blog: {
      title: 'DerniÃ¨res Perspectives',
      subtitle: 'Leadership Ã©clairÃ© et perspectives de recherche de notre Ã©quipe mondiale',
      readMore: 'Lire l\'article',
      readMoreArticles: 'Lire plus d\'articles',
      filterAllTopics: 'Tous les thÃ¨mes',
      filterAllCountries: 'Tous les pays',
      filterByTopic: 'ThÃ¨me',
      filterByCountry: 'Pays',
      items: [
        { category: 'AccÃ¨s au MarchÃ©', country: 'Europe', title: 'L\'Avenir des Accords de SantÃ© BasÃ©s sur la Valeur en Europe', excerpt: 'Comment les modÃ¨les contractuels innovants remodÃ¨lent les stratÃ©gies de prix et d\'accÃ¨s pharmaceutiques.', date: 'Rapport T4 2024' },
        { category: 'SantÃ© NumÃ©rique', country: 'USA', title: 'DÃ©couverte de MÃ©dicaments par l\'IA: Implications MarchÃ©', excerpt: 'Analyse du changement de paysage concurrentiel alors que l\'IA transforme la R&D pharmaceutique.', date: 'Note StratÃ©gique' },
        { category: 'Oncologie', country: 'Royaume-Uni', title: 'Dynamique du MarchÃ© de la MÃ©decine de PrÃ©cision 2025', excerpt: 'Analyse complÃ¨te des thÃ©rapies guidÃ©es par biomarqueurs et du paradigme de traitement oncologique.', date: 'Analyse Sectorielle' },
      ],
    },
    stats: {
      title: 'Impact Mondial',
      items: [
        { value: '50+', label: 'Pays Couverts' },
        { value: '10+', label: 'Clients Pharma' },
        { value: '120+', label: 'Projets LivrÃ©s' },
        { value: '15+', label: 'Ans d\'ExpÃ©rience' },
      ],
    },
    testimonials: {
      title: 'Perspectives Clients',
      subtitle: 'ApprouvÃ© par les principales entreprises pharmaceutiques et biotechnologiques mondiales',
    },
    contact: {
      title: 'Connectons-nous',
      subtitle: 'PrÃªt Ã  transformer votre stratÃ©gie de marchÃ© santÃ©? Notre Ã©quipe d\'experts est lÃ  pour vous aider.',
      cta: 'Planifier une Consultation',
      email: 'admin@bionixus.com',
      headquarters: 'Wyoming, USA',
    },
    localePrompt: {
      title: 'Vous ouvrez depuis {region}.',
      question: 'Voulez-vous passer Ã  {language} ?',
      yes: 'Oui',
      no: 'Non',
    },
    footer: {
      tagline: 'Intelligence StratÃ©gique en SantÃ©',
      copyright: 'Â© 2024 BioNixus. Tous droits rÃ©servÃ©s.',
      privacy: 'Politique de ConfidentialitÃ©',
      terms: 'Conditions d\'Utilisation',
    },
    cookieConsent: {
      message: 'Nous utilisons des cookies pour amÃ©liorer votre expÃ©rience et analyser le trafic. En cliquant sur Accepter, vous acceptez notre utilisation des cookies et notre Politique de ConfidentialitÃ©.',
      accept: 'Accepter',
      decline: 'Refuser',
      privacyLink: 'Politique de ConfidentialitÃ©',
    },
  },
  es: {
    nav: {
      services: 'Servicios',
      insights: 'Perspectivas',
      about: 'Nosotros',
      contact: 'Contacto',
    },
    hero: {
      tagline: 'EMEA Healthcare Market Research',
      title: 'EMEA Healthcare Market Research for Pharmaceutical Excellence',
      subtitle: 'Transform Physician & Hospital Insights into Strategic Intelligence Across UK, Europe & MENA Markets',
      valueProposition: 'We deliver comprehensive quantitative and qualitative market research services that transform clinical data into actionable pharmaceutical intelligence. Our specialized methodology captures authentic physician perspectives from NHS and private healthcare settings, hospital trends, and patient insights across UK, European, and MENA markets to power your drug development, market access, and commercial strategies.',
      serviceHighlights: ['UK NHS & Private Healthcare Research', 'Pan-European Physician Surveys', 'Qualitative KOL Interviews', 'Multi-Country Data Analytics', 'UK â€¢ Europe â€¢ MENA Coverage'],
      cta: 'Get UK Research Proposal',
      ctaSecondary: 'View European Case Studies',
      trustBar: 'Trusted by pharmaceutical companies in',
      trustCountries: 'UK â€¢ Germany â€¢ France â€¢ Spain â€¢ Italy â€¢ UAE â€¢ Saudi Arabia â€¢ Egypt â€¢ Kuwait â€¢ Qatar',
      complianceBadges: ['MHRA Compliant', 'EMA Aligned', 'GDPR Compliant', 'SFDA Compliant', 'ICH-GCP'],
    },
    services: {
      title: 'Nuestra Experiencia',
      subtitle: 'Soluciones integrales de investigaciÃ³n de mercado sanitario adaptadas a sus necesidades estratÃ©gicas',
      items: [
        {
          title: 'Acceso al Mercado y Precios',
          description: 'Navegue por paisajes de reembolso complejos con estrategias de precios basadas en evidencia.',
        },
        {
          title: 'Inteligencia Competitiva',
          description: 'MantÃ©ngase adelante con monitoreo competitivo en tiempo real y anÃ¡lisis de pipeline.',
        },
        {
          title: 'Mapeo del Recorrido del Paciente',
          description: 'Comprenda la experiencia completa del paciente desde el diagnÃ³stico hasta el tratamiento.',
        },
        {
          title: 'AnÃ¡lisis de KOL y Stakeholders',
          description: 'Identifique y comprometa a lÃ­deres de opiniÃ³n clave con mapeo de influencia basado en datos.',
        },
        {
          title: 'OptimizaciÃ³n de Ensayos ClÃ­nicos',
          description: 'Acelere el desarrollo con anÃ¡lisis de selecciÃ³n de sitios y estrategias de reclutamiento.',
        },
        {
          title: 'Excelencia en Lanzamiento',
          description: 'Maximice el impacto del lanzamiento con estrategias integradas go-to-market y pronÃ³sticos.',
        },
      ],
    },
    insights: {
      title: 'Ãšltimas Perspectivas',
      subtitle: 'Liderazgo de pensamiento y perspectivas de investigaciÃ³n de nuestro equipo global',
      readMore: 'Leer ArtÃ­culo',
      items: [
        {
          category: 'Acceso al Mercado',
          title: 'El Futuro de los Acuerdos de Salud Basados en Valor en Europa',
          excerpt: 'CÃ³mo los modelos de contrataciÃ³n innovadores estÃ¡n remodelando las estrategias de precios farmacÃ©uticos.',
          date: 'Informe Q4 2024',
        },
        {
          category: 'Salud Digital',
          title: 'Descubrimiento de FÃ¡rmacos con IA: Implicaciones de Mercado',
          excerpt: 'AnÃ¡lisis del cambio en el panorama competitivo mientras la IA transforma la I+D farmacÃ©utica.',
          date: 'Brief EstratÃ©gico',
        },
        {
          category: 'OncologÃ­a',
          title: 'DinÃ¡mica del Mercado de Medicina de PrecisiÃ³n 2025',
          excerpt: 'AnÃ¡lisis integral de terapias guiadas por biomarcadores y el paradigma de tratamiento oncolÃ³gico.',
          date: 'AnÃ¡lisis Industrial',
        },
      ],
    },
    blog: {
      title: 'Ãšltimas Perspectivas',
      subtitle: 'Liderazgo de pensamiento y perspectivas de investigaciÃ³n de nuestro equipo global',
      readMore: 'Leer ArtÃ­culo',
      readMoreArticles: 'Leer mÃ¡s artÃ­culos',
      filterAllTopics: 'Todos los temas',
      filterAllCountries: 'Todos los paÃ­ses',
      filterByTopic: 'Tema',
      filterByCountry: 'PaÃ­s',
      items: [
        { category: 'Acceso al Mercado', country: 'Europa', title: 'El Futuro de los Acuerdos de Salud Basados en Valor en Europa', excerpt: 'CÃ³mo los modelos de contrataciÃ³n innovadores estÃ¡n remodelando las estrategias de precios farmacÃ©uticos.', date: 'Informe Q4 2024' },
        { category: 'Salud Digital', country: 'EE. UU.', title: 'Descubrimiento de FÃ¡rmacos con IA: Implicaciones de Mercado', excerpt: 'AnÃ¡lisis del cambio en el panorama competitivo mientras la IA transforma la I+D farmacÃ©utica.', date: 'Brief EstratÃ©gico' },
        { category: 'OncologÃ­a', country: 'Reino Unido', title: 'DinÃ¡mica del Mercado de Medicina de PrecisiÃ³n 2025', excerpt: 'AnÃ¡lisis integral de terapias guiadas por biomarcadores y el paradigma de tratamiento oncolÃ³gico.', date: 'AnÃ¡lisis Industrial' },
      ],
    },
    stats: {
      title: 'Impacto Global',
      items: [
        { value: '50+', label: 'PaÃ­ses Cubiertos' },
        { value: '10+', label: 'Clientes Pharma' },
        { value: '120+', label: 'Proyectos Entregados' },
        { value: '15+', label: 'AÃ±os de Experiencia' },
      ],
    },
    testimonials: {
      title: 'Perspectivas de Clientes',
      subtitle: 'Confiado por empresas farmacÃ©uticas y biotecnolÃ³gicas lÃ­deres en todo el mundo',
    },
    contact: {
      title: 'Conectemos',
      subtitle: 'Â¿Listo para transformar su estrategia de mercado sanitario? Nuestro equipo de expertos estÃ¡ aquÃ­ para ayudar.',
      cta: 'Programar Consulta',
      email: 'admin@bionixus.com',
      headquarters: 'Wyoming, USA',
    },
    localePrompt: {
      title: 'EstÃ¡ abriendo desde {region}.',
      question: 'Â¿Desea cambiar a {language}?',
      yes: 'SÃ­',
      no: 'No',
    },
    footer: {
      tagline: 'Inteligencia EstratÃ©gica en Salud',
      copyright: 'Â© 2024 BioNixus. Todos los derechos reservados.',
      privacy: 'PolÃ­tica de Privacidad',
      terms: 'TÃ©rminos de Servicio',
    },
    cookieConsent: {
      message: 'Utilizamos cookies para mejorar su experiencia y analizar el trÃ¡fico del sitio. Al hacer clic en Aceptar, acepta nuestro uso de cookies y nuestra PolÃ­tica de Privacidad.',
      accept: 'Aceptar',
      decline: 'Rechazar',
      privacyLink: 'PolÃ­tica de Privacidad',
    },
  },
  zh: {
    nav: {
      services: 'æœåŠ¡',
      insights: 'æ´å¯Ÿ',
      about: 'å…³äºæˆ‘ä»¬',
      contact: 'è”ç³»æˆ‘ä»¬',
    },
    hero: {
      tagline: 'EMEA Healthcare Market Research',
      title: 'EMEA Healthcare Market Research for Pharmaceutical Excellence',
      subtitle: 'Transform Physician & Hospital Insights into Strategic Intelligence Across UK, Europe & MENA Markets',
      valueProposition: 'We deliver comprehensive quantitative and qualitative market research services that transform clinical data into actionable pharmaceutical intelligence. Our specialized methodology captures authentic physician perspectives from NHS and private healthcare settings, hospital trends, and patient insights across UK, European, and MENA markets to power your drug development, market access, and commercial strategies.',
      serviceHighlights: ['UK NHS & Private Healthcare Research', 'Pan-European Physician Surveys', 'Qualitative KOL Interviews', 'Multi-Country Data Analytics', 'UK â€¢ Europe â€¢ MENA Coverage'],
      cta: 'Get UK Research Proposal',
      ctaSecondary: 'View European Case Studies',
      trustBar: 'Trusted by pharmaceutical companies in',
      trustCountries: 'UK â€¢ Germany â€¢ France â€¢ Spain â€¢ Italy â€¢ UAE â€¢ Saudi Arabia â€¢ Egypt â€¢ Kuwait â€¢ Qatar',
      complianceBadges: ['MHRA Compliant', 'EMA Aligned', 'GDPR Compliant', 'SFDA Compliant', 'ICH-GCP'],
    },
    services: {
      title: 'æˆ‘ä»¬çš„ä¸“ä¸šé¢†åŸŸ',
      subtitle: 'æ ¹æ®æ‚¨çš„æˆ˜ç•¥éœ€æ±‚é‡èº«å®šåˆ¶çš„å…¨é¢åŒ»ç–—å¥åº·å¸‚åœºç ”ç©¶è§£å†³æ–¹æ¡ˆ',
      items: [
        {
          title: 'å¸‚åœºå‡†å…¥ä¸å®šä»·',
          description: 'é€šè¿‡åŸºäºè¯æ®çš„å®šä»·ç­–ç•¥å’Œä»˜æ¬¾æ–¹å‚ä¸æ¡†æ¶ï¼Œé©¾é©­å¤æ‚çš„æŠ¥é”€ç¯å¢ƒã€‚',
        },
        {
          title: 'ç«äº‰æƒ…æŠ¥',
          description: 'é€šè¿‡å®æ—¶ç«äº‰ç›‘æ§ã€ç®¡çº¿åˆ†æå’Œæˆ˜ç•¥å®šä½æ´å¯Ÿä¿æŒé¢†å…ˆã€‚',
        },
        {
          title: 'æ‚£è€…æ—…ç¨‹æ˜ å°„',
          description: 'äº†è§£ä»è¯Šæ–­åˆ°æ²»ç–—çš„å®Œæ•´æ‚£è€…ä½“éªŒï¼Œä»¥ä¼˜åŒ–æ¥è§¦ç‚¹å’Œç»“æœã€‚',
        },
        {
          title: 'KOLä¸åˆ©ç›Šç›¸å…³è€…åˆ†æ',
          description: 'é€šè¿‡æ•°æ®é©±åŠ¨çš„å½±å“åŠ›æ˜ å°„å’Œå…³ç³»ç­–ç•¥è¯†åˆ«å’Œå¸å¼•å…³é”®æ„è§é¢†è¢–ã€‚',
        },
        {
          title: 'ä¸´åºŠè¯•éªŒä¼˜åŒ–',
          description: 'é€šè¿‡ç«™ç‚¹é€‰æ‹©åˆ†æã€æ‚£è€…æ‹›å‹Ÿç­–ç•¥å’Œæ–¹æ¡ˆä¼˜åŒ–åŠ é€Ÿå¼€å‘ã€‚',
        },
        {
          title: 'ä¸Šå¸‚å“è¶Š',
          description: 'é€šè¿‡æ•´åˆçš„å¸‚åœºè¿›å…¥ç­–ç•¥ã€é¢„æµ‹å’Œå¸‚åœºå¡‘é€ è®¡åˆ’æœ€å¤§åŒ–ä¸Šå¸‚å½±å“ã€‚',
        },
      ],
    },
    insights: {
      title: 'æœ€æ–°æ´å¯Ÿ',
      subtitle: 'æ¥è‡ªæˆ‘ä»¬å…¨çƒå›¢é˜Ÿçš„æ€æƒ³é¢†å¯¼åŠ›å’Œç ”ç©¶è§†è§’',
      readMore: 'é˜…è¯»æ–‡ç« ',
      items: [
        {
          category: 'å¸‚åœºå‡†å…¥',
          title: 'æ¬§æ´²åŸºäºä»·å€¼çš„åŒ»ç–—åè®®çš„æœªæ¥',
          excerpt: 'åˆ›æ–°åˆåŒæ¨¡å¼å¦‚ä½•é‡å¡‘ä¸»è¦æ¬§æ´²å¸‚åœºçš„åˆ¶è¯å®šä»·å’Œå‡†å…¥ç­–ç•¥ã€‚',
          date: '2024å¹´ç¬¬å››å­£åº¦æŠ¥å‘Š',
        },
        {
          category: 'æ•°å­—å¥åº·',
          title: 'AIé©±åŠ¨çš„è¯ç‰©å‘ç°ï¼šå¸‚åœºå½±å“',
          excerpt: 'åˆ†æäººå·¥æ™ºèƒ½æ”¹å˜åˆ¶è¯ç ”å‘å’Œä¸Šå¸‚æ—¶é—´æ—¶çš„ç«äº‰æ ¼å±€å˜åŒ–ã€‚',
          date: 'æˆ˜ç•¥ç®€æŠ¥',
        },
        {
          category: 'è‚¿ç˜¤å­¦',
          title: '2025å¹´ç²¾å‡†åŒ»ç–—å¸‚åœºåŠ¨æ€',
          excerpt: 'å¯¹ç”Ÿç‰©æ ‡å¿—ç‰©é©±åŠ¨ç–—æ³•å’Œä¸æ–­å‘å±•çš„è‚¿ç˜¤æ²»ç–—èŒƒå¼çš„å…¨é¢åˆ†æã€‚',
          date: 'è¡Œä¸šåˆ†æ',
        },
      ],
    },
    blog: {
      title: 'æœ€æ–°æ´å¯Ÿ',
      subtitle: 'æ¥è‡ªæˆ‘ä»¬å…¨çƒå›¢é˜Ÿçš„æ€æƒ³é¢†å¯¼åŠ›å’Œç ”ç©¶è§†è§’',
      readMore: 'é˜…è¯»æ–‡ç« ',
      readMoreArticles: 'é˜…è¯»æ›´å¤šæ–‡ç« ',
      filterAllTopics: 'å…¨éƒ¨ä¸»é¢˜',
      filterAllCountries: 'å…¨éƒ¨å›½å®¶',
      filterByTopic: 'ä¸»é¢˜',
      filterByCountry: 'å›½å®¶',
      items: [
        { category: 'å¸‚åœºå‡†å…¥', country: 'æ¬§æ´²', title: 'æ¬§æ´²åŸºäºä»·å€¼çš„åŒ»ç–—åè®®çš„æœªæ¥', excerpt: 'åˆ›æ–°åˆåŒæ¨¡å¼å¦‚ä½•é‡å¡‘ä¸»è¦æ¬§æ´²å¸‚åœºçš„åˆ¶è¯å®šä»·å’Œå‡†å…¥ç­–ç•¥ã€‚', date: '2024å¹´ç¬¬å››å­£åº¦æŠ¥å‘Š' },
        { category: 'æ•°å­—å¥åº·', country: 'ç¾å›½', title: 'AIé©±åŠ¨çš„è¯ç‰©å‘ç°ï¼šå¸‚åœºå½±å“', excerpt: 'åˆ†æäººå·¥æ™ºèƒ½æ”¹å˜åˆ¶è¯ç ”å‘å’Œä¸Šå¸‚æ—¶é—´æ—¶çš„ç«äº‰æ ¼å±€å˜åŒ–ã€‚', date: 'æˆ˜ç•¥ç®€æŠ¥' },
        { category: 'è‚¿ç˜¤å­¦', country: 'è‹±å›½', title: '2025å¹´ç²¾å‡†åŒ»ç–—å¸‚åœºåŠ¨æ€', excerpt: 'å¯¹ç”Ÿç‰©æ ‡å¿—ç‰©é©±åŠ¨ç–—æ³•å’Œä¸æ–­å‘å±•çš„è‚¿ç˜¤æ²»ç–—èŒƒå¼çš„å…¨é¢åˆ†æã€‚', date: 'è¡Œä¸šåˆ†æ' },
      ],
    },
    stats: {
      title: 'å…¨çƒå½±å“',
      items: [
        { value: '50+', label: 'è¦†ç›–å›½å®¶' },
        { value: '10+', label: 'åˆ¶è¯å®¢æˆ·' },
        { value: '120+', label: 'äº¤ä»˜é¡¹ç›®' },
        { value: '15+', label: 'å¹´ç»éªŒ' },
      ],
    },
    testimonials: {
      title: 'å®¢æˆ·è§‚ç‚¹',
      subtitle: 'å—åˆ°å…¨çƒé¢†å…ˆåˆ¶è¯å’Œç”Ÿç‰©æŠ€æœ¯å…¬å¸çš„ä¿¡èµ–',
    },
    contact: {
      title: 'è®©æˆ‘ä»¬è”ç³»',
      subtitle: 'å‡†å¤‡å¥½è½¬å˜æ‚¨çš„åŒ»ç–—å¥åº·å¸‚åœºæˆ˜ç•¥äº†å—ï¼Ÿæˆ‘ä»¬çš„ä¸“å®¶å›¢é˜Ÿéšæ—¶ä¸ºæ‚¨æœåŠ¡ã€‚',
      cta: 'é¢„çº¦å’¨è¯¢',
      email: 'admin@bionixus.com',
      headquarters: 'Wyoming, USA',
    },
    localePrompt: {
      title: 'æ‚¨æ­£åœ¨ä» {region} æ‰“å¼€ã€‚',
      question: 'æ˜¯å¦åˆ‡æ¢åˆ° {language}ï¼Ÿ',
      yes: 'æ˜¯',
      no: 'å¦',
    },
    footer: {
      tagline: 'æˆ˜ç•¥åŒ»ç–—å¥åº·æ™ºèƒ½',
      copyright: 'Â© 2024 BioNixusã€‚ä¿ç•™æ‰€æœ‰æƒåˆ©ã€‚',
      privacy: 'éšç§æ”¿ç­–',
      terms: 'æœåŠ¡æ¡æ¬¾',
    },
    cookieConsent: {
      message: 'æˆ‘ä»¬ä½¿ç”¨ Cookie æ¥æ”¹å–„æ‚¨çš„ä½“éªŒå¹¶åˆ†æç½‘ç«™æµé‡ã€‚ç‚¹å‡»â€œæ¥å—â€å³è¡¨ç¤ºæ‚¨åŒæ„æˆ‘ä»¬ä½¿ç”¨ Cookie å’Œæˆ‘ä»¬çš„éšç§æ”¿ç­–ã€‚',
      accept: 'æ¥å—',
      decline: 'æ‹’ç»',
      privacyLink: 'éšç§æ”¿ç­–',
    },
  },
  ar: {
    nav: {
      services: 'Ø§Ù„Ø®Ø¯Ù…Ø§Øª',
      insights: 'Ø§Ù„Ø±Ø¤Ù‰',
      about: 'Ù…Ù† Ù†Ø­Ù†',
      contact: 'Ø§ØªØµÙ„ Ø¨Ù†Ø§',
    },
    hero: {
      tagline: 'Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ø³ÙˆÙ‚ Ø§Ù„ØµØ­ÙŠØ© ÙÙŠ Ø§Ù„Ø´Ø±Ù‚ Ø§Ù„Ø£ÙˆØ³Ø· ÙˆØ§Ù„Ø®Ù„ÙŠØ¬',
      title: 'Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ø³ÙˆÙ‚ Ø§Ù„ØµØ­ÙŠØ© ÙˆØ§Ù„Ø¯ÙˆØ§Ø¦ÙŠØ© ÙÙŠ Ø§Ù„Ø´Ø±Ù‚ Ø§Ù„Ø£ÙˆØ³Ø· ÙˆØ¯ÙˆÙ„ Ø§Ù„Ø®Ù„ÙŠØ¬',
      subtitle: 'Ø­ÙˆÙ‘Ù„ Ø±Ø¤Ù‰ Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ ÙˆØ§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø¥Ù„Ù‰ Ø°ÙƒØ§Ø¡ Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠ Ø¹Ø¨Ø± Ø£Ø³ÙˆØ§Ù‚ Ø§Ù„Ø®Ù„ÙŠØ¬ ÙˆØ´Ù…Ø§Ù„ Ø£ÙØ±ÙŠÙ‚ÙŠØ§',
      valueProposition: 'Ù†Ù‚Ø¯Ù… Ø®Ø¯Ù…Ø§Øª Ø£Ø¨Ø­Ø§Ø« Ø³ÙˆÙ‚ ÙƒÙ…ÙŠØ© ÙˆÙ†ÙˆØ¹ÙŠØ© Ø´Ø§Ù…Ù„Ø© ØªØ­ÙˆÙ„ Ø§Ù„Ø¨ÙŠØ§Ù†Ø§Øª Ø§Ù„Ø³Ø±ÙŠØ±ÙŠØ© Ø¥Ù„Ù‰ Ù…Ø¹Ù„ÙˆÙ…Ø§Øª Ø¯ÙˆØ§Ø¦ÙŠØ© Ù‚Ø§Ø¨Ù„Ø© Ù„Ù„ØªÙ†ÙÙŠØ°. Ù…Ù†Ù‡Ø¬ÙŠØªÙ†Ø§ Ø§Ù„Ù…ØªØ®ØµØµØ© ØªÙ„ØªÙ‚Ø· ÙˆØ¬Ù‡Ø§Øª Ù†Ø¸Ø± Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ Ø§Ù„Ø­Ù‚ÙŠÙ‚ÙŠØ© Ù…Ù† Ø§Ù„Ù‚Ø·Ø§Ø¹ÙŠÙ† Ø§Ù„Ø­ÙƒÙˆÙ…ÙŠ ÙˆØ§Ù„Ø®Ø§ØµØŒ Ø§ØªØ¬Ø§Ù‡Ø§Øª Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§ØªØŒ ÙˆØ±Ø¤Ù‰ Ø§Ù„Ù…Ø±Ø¶Ù‰ Ø¹Ø¨Ø± Ø£Ø³ÙˆØ§Ù‚ Ø¯ÙˆÙ„ Ø§Ù„Ø®Ù„ÙŠØ¬ ÙˆØ§Ù„Ø´Ø±Ù‚ Ø§Ù„Ø£ÙˆØ³Ø· Ù„Ø¯Ø¹Ù… Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ§Øª ØªØ·ÙˆÙŠØ± Ø§Ù„Ø£Ø¯ÙˆÙŠØ©ØŒ Ø§Ù„ÙˆØµÙˆÙ„ Ù„Ù„Ø³ÙˆÙ‚ØŒ ÙˆØ§Ù„ØªØ³ÙˆÙŠÙ‚ Ø§Ù„ØªØ¬Ø§Ø±ÙŠ.',
      serviceHighlights: ['Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø­ÙƒÙˆÙ…ÙŠØ© ÙˆØ§Ù„Ø®Ø§ØµØ©', 'Ø§Ø³ØªØ¨ÙŠØ§Ù†Ø§Øª Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ Ø§Ù„ÙƒÙ…ÙŠØ©', 'Ù…Ù‚Ø§Ø¨Ù„Ø§Øª Ø§Ù„Ø®Ø¨Ø±Ø§Ø¡ Ø§Ù„Ù†ÙˆØ¹ÙŠØ©', 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ø¨ÙŠØ§Ù†Ø§Øª Ù…ØªØ¹Ø¯Ø¯ Ø§Ù„Ø¯ÙˆÙ„', 'ØªØºØ·ÙŠØ© Ø´Ø§Ù…Ù„Ø© Ù„Ù„Ø®Ù„ÙŠØ¬ ÙˆØ§Ù„Ø´Ø±Ù‚ Ø§Ù„Ø£ÙˆØ³Ø·'],
      cta: 'Ø§Ø­ØµÙ„ Ø¹Ù„Ù‰ Ø¹Ø±Ø¶ Ø£Ø³Ø¹Ø§Ø±',
      ctaSecondary: 'Ø§Ø³ØªØ¹Ø±Ø¶ Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ø­Ø§Ù„Ø©',
      trustBar: 'Ù…ÙˆØ«ÙˆÙ‚ Ø¨Ù‡ Ù…Ù† Ù‚Ø¨Ù„ Ø´Ø±ÙƒØ§Øª Ø§Ù„Ø£Ø¯ÙˆÙŠØ© ÙÙŠ',
      trustCountries: 'Ø§Ù„Ø³Ø¹ÙˆØ¯ÙŠØ© â€¢ Ø§Ù„Ø¥Ù…Ø§Ø±Ø§Øª â€¢ Ø§Ù„ÙƒÙˆÙŠØª â€¢ Ù‚Ø·Ø± â€¢ Ù…ØµØ± â€¢ Ø§Ù„Ù…ØºØ±Ø¨ â€¢ Ø§Ù„Ø¬Ø²Ø§Ø¦Ø± â€¢ ØªÙˆÙ†Ø³',
      complianceBadges: ['MHRA Compliant', 'EMA Aligned', 'GDPR Compliant', 'SFDA Compliant', 'ICH-GCP'],
    },
    services: {
      title: 'Ø®Ø¨Ø±ØªÙ†Ø§',
      subtitle: 'Ø­Ù„ÙˆÙ„ Ø´Ø§Ù…Ù„Ø© Ù„Ø£Ø¨Ø­Ø§Ø« Ø³ÙˆÙ‚ Ø§Ù„Ø±Ø¹Ø§ÙŠØ© Ø§Ù„ØµØ­ÙŠØ© Ù…ØµÙ…Ù…Ø© ÙˆÙÙ‚Ø§Ù‹ Ù„Ø§Ø­ØªÙŠØ§Ø¬Ø§ØªÙƒ Ø§Ù„Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ©',
      servicePrimaryAr: [
        {
          title: 'Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ø³ÙˆÙ‚ Ø§Ù„ÙƒÙ…ÙŠØ© ÙˆØ§Ø³ØªØ¨ÙŠØ§Ù†Ø§Øª Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ ÙÙŠ Ø¯ÙˆÙ„ Ø§Ù„Ø®Ù„ÙŠØ¬ ÙˆØ§Ù„Ø´Ø±Ù‚ Ø§Ù„Ø£ÙˆØ³Ø·',
          lead: 'Ø±Ø¤Ù‰ Ø¥Ø­ØµØ§Ø¦ÙŠØ© Ù‚ÙˆÙŠØ© Ù…Ù† Ø§Ø³ØªØ¨ÙŠØ§Ù†Ø§Øª ÙˆØ§Ø³Ø¹Ø© Ø§Ù„Ù†Ø·Ø§Ù‚ Ù„Ù„Ø£Ø·Ø¨Ø§Ø¡ ÙˆØ§Ù„Ù…Ù‡Ù†ÙŠÙŠÙ† Ø§Ù„ØµØ­ÙŠÙŠÙ† Ø¹Ø¨Ø± Ø£Ø³ÙˆØ§Ù‚ Ø§Ù„Ø®Ù„ÙŠØ¬ØŒ Ø´Ù…Ø§Ù„ Ø£ÙØ±ÙŠÙ‚ÙŠØ§ ÙˆØ§Ù„Ø´Ø±Ù‚ Ø§Ù„Ø£ÙˆØ³Ø·. Ù…Ù†Ù‡Ø¬ÙŠØ§ØªÙ†Ø§ Ø§Ù„ÙƒÙ…ÙŠØ© ØªÙ‚Ø¯Ù… Ø§Ù„Ø£Ø¯Ù„Ø© Ø§Ù„ØªÙŠ ØªØ­ØªØ§Ø¬Ù‡Ø§ Ù„Ø§ØªØ®Ø§Ø° Ù‚Ø±Ø§Ø±Ø§Øª Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ©.',
          countries: [
            { name: 'Ø§Ù„Ù…Ù…Ù„ÙƒØ© Ø§Ù„Ø¹Ø±Ø¨ÙŠØ© Ø§Ù„Ø³Ø¹ÙˆØ¯ÙŠØ©', items: ['Ø§Ø³ØªØ¨ÙŠØ§Ù†Ø§Øª Ø£Ø·Ø¨Ø§Ø¡ ÙˆØ²Ø§Ø±Ø© Ø§Ù„ØµØ­Ø© ÙˆØ§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø¬Ø§Ù…Ø¹ÙŠØ© ÙˆØ§Ù„ØªØ®ØµØµÙŠØ© (Ø§Ù„Ø±ÙŠØ§Ø¶ØŒ Ø¬Ø¯Ø©ØŒ Ø§Ù„Ø¯Ù…Ø§Ù…)', 'ØªØ­Ù„ÙŠÙ„ Ø³Ù„ÙˆÙƒ Ø§Ù„ÙˆØµÙØ§Øª Ø§Ù„Ø·Ø¨ÙŠØ© ÙˆØ§Ù„ØªÙØ¶ÙŠÙ„Ø§Øª Ø§Ù„Ø¹Ù„Ø§Ø¬ÙŠØ©', 'Ø£Ø¨Ø­Ø§Ø« Ù…Ø¯Ù† Ø§Ù„Ù…Ù„Ùƒ ÙÙ‡Ø¯ Ø§Ù„Ø·Ø¨ÙŠØ© ÙˆÙ…Ø¬Ù…Ø¹ Ø§Ù„Ù…Ù„Ùƒ Ø¹Ø¨Ø¯Ø§Ù„Ù„Ù‡ Ø§Ù„Ø·Ø¨ÙŠ', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø±Ø¤ÙŠØ© 2030 ÙˆØ§Ù„ØªØ­ÙˆÙ„ Ø§Ù„ØµØ­ÙŠ', 'ØªØ­Ù„ÙŠÙ„ Ø­Ø¬Ù… Ø§Ù„Ø³ÙˆÙ‚ ÙˆØ§Ù„ØªÙ†Ø¨Ø¤ Ø¨Ø§Ù„Ø§ØªØ¬Ø§Ù‡Ø§Øª'] },
            { name: 'Ø§Ù„Ø¥Ù…Ø§Ø±Ø§Øª Ø§Ù„Ø¹Ø±Ø¨ÙŠØ© Ø§Ù„Ù…ØªØ­Ø¯Ø©', items: ['Ø£Ø¨Ø­Ø§Ø« Ù‡ÙŠØ¦Ø© Ø§Ù„ØµØ­Ø© Ø¨Ø¯Ø¨ÙŠ (DHA) ÙˆØ¯Ø§Ø¦Ø±Ø© Ø§Ù„ØµØ­Ø© Ø£Ø¨ÙˆØ¸Ø¨ÙŠ (DOH)', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø®Ø§ØµØ© ÙˆØ§Ù„Ù…Ø±Ø§ÙƒØ² Ø§Ù„ØªØ®ØµØµÙŠØ©', 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ø³ÙŠØ§Ø­Ø© Ø§Ù„Ø¹Ù„Ø§Ø¬ÙŠØ© ÙˆØ§Ù„Ø±Ø¹Ø§ÙŠØ© Ø§Ù„ØªØ®ØµØµÙŠØ©', 'Ø§Ø³ØªØ¨ÙŠØ§Ù†Ø§Øª Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ ÙÙŠ Ø¯Ø¨ÙŠØŒ Ø£Ø¨ÙˆØ¸Ø¨ÙŠØŒ Ø§Ù„Ø´Ø§Ø±Ù‚Ø©', 'Ø£Ø¨Ø­Ø§Ø« Ù…Ø¯ÙŠÙ†Ø© Ø¯Ø¨ÙŠ Ø§Ù„Ø·Ø¨ÙŠØ© ÙˆÙ…Ø³ØªØ´ÙÙ‰ ÙƒÙ„ÙŠÙÙ„Ø§Ù†Ø¯ ÙƒÙ„ÙŠÙ†Ùƒ'] },
            { name: 'Ø§Ù„ÙƒÙˆÙŠØª', items: ['Ø¯Ø±Ø§Ø³Ø§Øª Ù†Ø¸Ø§Ù… Ø§Ù„Ø±Ø¹Ø§ÙŠØ© Ø§Ù„ØµØ­ÙŠØ© Ø¨ÙˆØ²Ø§Ø±Ø© Ø§Ù„ØµØ­Ø©', 'Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„ØªØ®ØµØµÙŠØ© ÙˆØ§Ù„Ù…Ø¬Ù…Ø¹Ø§Øª Ø§Ù„Ø·Ø¨ÙŠØ©', 'ØªØ­Ù„ÙŠÙ„ ØªÙØ¶ÙŠÙ„Ø§Øª Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ ÙˆØ§Ù„Ø£Ù†Ù…Ø§Ø· Ø§Ù„Ø¹Ù„Ø§Ø¬ÙŠØ©'] },
            { name: 'Ù‚Ø·Ø±', items: ['Ø£Ø¨Ø­Ø§Ø« Ù…Ø¤Ø³Ø³Ø© Ø­Ù…Ø¯ Ø§Ù„Ø·Ø¨ÙŠØ© ÙˆØ§Ù„Ù…Ø¤Ø³Ø³Ø§Øª Ø§Ù„ØµØ­ÙŠØ©', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø®Ø§ØµØ© ÙˆØ§Ù„Ø¹ÙŠØ§Ø¯Ø§Øª Ø§Ù„ØªØ®ØµØµÙŠØ©', 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ù…Ø¨Ø§Ø¯Ø±Ø§Øª Ø§Ù„ØµØ­ÙŠØ© ÙˆØ§Ù„Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ© Ø§Ù„ÙˆØ·Ù†ÙŠØ© Ù„Ù„ØµØ­Ø©'] },
            { name: 'Ù…ØµØ±', items: ['Ø£Ø¨Ø­Ø§Ø« Ø£ÙƒØ¨Ø± Ø³ÙˆÙ‚ Ø¯ÙˆØ§Ø¦ÙŠ ÙÙŠ Ø´Ù…Ø§Ù„ Ø£ÙØ±ÙŠÙ‚ÙŠØ§', 'Ø§Ø³ØªØ¨ÙŠØ§Ù†Ø§Øª Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø­ÙƒÙˆÙ…ÙŠØ© ÙˆØ§Ù„Ø¬Ø§Ù…Ø¹ÙŠØ© (Ø§Ù„Ù‚Ø§Ù‡Ø±Ø©ØŒ Ø§Ù„Ø¥Ø³ÙƒÙ†Ø¯Ø±ÙŠØ©)', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ ÙˆØ§Ù„Ù…Ø±Ø§ÙƒØ² Ø§Ù„Ø·Ø¨ÙŠØ© Ø§Ù„ØªØ®ØµØµÙŠØ©', 'ØªØ­Ù„ÙŠÙ„ Ø´Ø¨ÙƒØ§Øª Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª ÙˆØ§Ù„Ø±Ø¹Ø§ÙŠØ© Ø§Ù„Ø£ÙˆÙ„ÙŠØ©', 'Ø£Ø¨Ø­Ø§Ø« Ø§Ù„ØªØ£Ù…ÙŠÙ† Ø§Ù„ØµØ­ÙŠ Ø§Ù„Ø´Ø§Ù…Ù„'] },
            { name: 'Ø§Ù„Ù…ØºØ±Ø¨', items: ['Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ù†Ø¸Ø§Ù… Ø§Ù„ØµØ­ÙŠ ÙÙŠ Ø§Ù„Ø±Ø¨Ø§Ø·ØŒ Ø§Ù„Ø¯Ø§Ø± Ø§Ù„Ø¨ÙŠØ¶Ø§Ø¡ØŒ Ù…Ø±Ø§ÙƒØ´', 'Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø¬Ø§Ù…Ø¹ÙŠØ© CHU', 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ ÙˆØ§Ù„Ø¹ÙŠØ§Ø¯Ø§Øª Ø§Ù„ØªØ®ØµØµÙŠØ©'] },
            { name: 'Ø§Ù„Ø¬Ø²Ø§Ø¦Ø±', items: ['Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„ØµØ­ÙŠ Ø§Ù„Ø¹Ø§Ù… ÙˆØ§Ù„Ø®Ø§Øµ', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø¬Ø§Ù…Ø¹ÙŠØ© ÙÙŠ Ø§Ù„Ø¬Ø²Ø§Ø¦Ø±ØŒ ÙˆÙ‡Ø±Ø§Ù†ØŒ Ù‚Ø³Ù†Ø·ÙŠÙ†Ø©', 'ØªØ­Ù„ÙŠÙ„ Ø³ÙˆÙ‚ Ø§Ù„Ø£Ø¯ÙˆÙŠØ© ÙˆØ§Ù„ØªÙˆØ²ÙŠØ¹'] },
            { name: 'ØªÙˆÙ†Ø³', items: ['Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ù†Ø¸Ø§Ù… Ø§Ù„ØµØ­ÙŠ Ø§Ù„ÙˆØ·Ù†ÙŠ', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø¬Ø§Ù…Ø¹ÙŠØ© ÙˆØ§Ù„Ù…Ø±Ø§ÙƒØ² Ø§Ù„Ù…ØªØ®ØµØµØ©', 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ Ø§Ù„ØµØ­ÙŠ'] },
            { name: 'Ø¥ÙŠØ±Ø§Ù†', items: ['Ø£Ø¨Ø­Ø§Ø« Ø³ÙˆÙ‚ Ø§Ù„Ø£Ø¯ÙˆÙŠØ© Ø§Ù„Ø¥ÙŠØ±Ø§Ù†ÙŠ', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª ÙˆØ§Ù„Ù…Ø±Ø§ÙƒØ² Ø§Ù„Ø¨Ø­Ø«ÙŠØ© Ø§Ù„Ø·Ø¨ÙŠØ©', 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ù†Ø¸Ø§Ù… Ø§Ù„ØµØ­ÙŠ ÙˆØ§Ù„ØªØµÙ†ÙŠØ¹ Ø§Ù„Ù…Ø­Ù„ÙŠ Ù„Ù„Ø£Ø¯ÙˆÙŠØ©'] },
          ],
          deliverables: 'Ø§Ù„Ù…Ø®Ø±Ø¬Ø§Øª: ØªÙ‚Ø§Ø±ÙŠØ± Ø¥Ø­ØµØ§Ø¦ÙŠØ© Ø´Ø§Ù…Ù„Ø©ØŒ ØªÙ‚Ø¯ÙŠØ±Ø§Øª Ø­Ø¬Ù… Ø§Ù„Ø³ÙˆÙ‚ØŒ ØªØ­Ù„ÙŠÙ„ Ù…Ø³Ø§Ø±Ø§Øª Ø§Ù„Ø¹Ù„Ø§Ø¬ØŒ Ø§Ù„ØªÙ†Ø¨Ø¤ Ø¨Ø§Ù„Ø§ØªØ¬Ø§Ù‡Ø§ØªØŒ ØªØ­Ù„ÙŠÙ„ Ø§Ù„ØªÙ‚Ø³ÙŠÙ…ØŒ Ø±Ø¤Ù‰ Ù…Ù‚Ø§Ø±Ù†Ø© Ø¹Ø¨Ø± Ø§Ù„Ø¯ÙˆÙ„ØŒ Ù„ÙˆØ­Ø§Øª Ø§Ù„Ø°ÙƒØ§Ø¡ Ø§Ù„ØªÙ†Ø§ÙØ³ÙŠ',
        },
        {
          title: 'Ø§Ù„Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ù†ÙˆØ¹ÙŠØ© ÙˆØ±Ø¤Ù‰ Ø§Ù„Ø®Ø¨Ø±Ø§Ø¡ Ø§Ù„Ø·Ø¨ÙŠÙŠÙ† ÙÙŠ Ø§Ù„Ø´Ø±Ù‚ Ø§Ù„Ø£ÙˆØ³Ø·',
          lead: 'Ø£Ø¨Ø­Ø§Ø« Ù†ÙˆØ¹ÙŠØ© Ù…ØªØ¹Ù…Ù‚Ø© ØªÙ„ØªÙ‚Ø· ÙˆØ¬Ù‡Ø§Øª Ø§Ù„Ù†Ø¸Ø± Ø§Ù„Ø³Ø±ÙŠØ±ÙŠØ© Ø§Ù„Ø¯Ù‚ÙŠÙ‚Ø©ØŒ Ø§Ù„Ø§Ø­ØªÙŠØ§Ø¬Ø§Øª Ø§Ù„Ø·Ø¨ÙŠØ© ØºÙŠØ± Ø§Ù„Ù…Ù„Ø¨Ø§Ø©ØŒ ÙˆØ§Ù„Ø°ÙƒØ§Ø¡ Ø§Ù„Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠ Ù…Ù† Ø®Ù„Ø§Ù„ Ø§Ù„ØªÙØ§Ø¹Ù„ Ù…Ø¹ Ø§Ù„Ø®Ø¨Ø±Ø§Ø¡ Ø¹Ø¨Ø± Ø§Ù„Ø£Ø³ÙˆØ§Ù‚ Ø§Ù„Ø±Ø¦ÙŠØ³ÙŠØ©.',
          countries: [
            { name: 'Ø§Ù„Ù…Ù…Ù„ÙƒØ© Ø§Ù„Ø¹Ø±Ø¨ÙŠØ© Ø§Ù„Ø³Ø¹ÙˆØ¯ÙŠØ© - Ø§Ù„Ø¨Ø­Ø« Ø§Ù„Ù†ÙˆØ¹ÙŠ', items: ['Ù…Ù‚Ø§Ø¨Ù„Ø§Øª Ù…ØªØ¹Ù…Ù‚Ø© Ù…Ø¹ Ø§Ø³ØªØ´Ø§Ø±ÙŠÙŠÙ† ÙˆØ£Ø·Ø¨Ø§Ø¡ Ù…ØªØ®ØµØµÙŠÙ†', 'Ù…Ø¬Ù…ÙˆØ¹Ø§Øª Ø§Ù„Ù†Ù‚Ø§Ø´ Ù…Ø¹ Ù…Ø¯ÙŠØ±ÙŠ Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª', 'Ù…Ø¬Ø§Ù„Ø³ Ø§Ø³ØªØ´Ø§Ø±ÙŠØ© Ù„Ù„Ø®Ø¨Ø±Ø§Ø¡ Ø§Ù„Ø·Ø¨ÙŠÙŠÙ† KOL', 'Ø¯Ø±Ø§Ø³Ø§Øª ØªØ¬Ø±Ø¨Ø© Ø§Ù„Ù…Ø±Ø¶Ù‰', 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ø§Ø­ØªÙŠØ§Ø¬Ø§Øª ØºÙŠØ± Ø§Ù„Ù…Ù„Ø¨Ø§Ø© ÙÙŠ Ø§Ù„ØªØ®ØµØµØ§Øª Ø§Ù„Ø¹Ù„Ø§Ø¬ÙŠØ©'] },
            { name: 'Ø§Ù„Ø¥Ù…Ø§Ø±Ø§Øª Ø§Ù„Ø¹Ø±Ø¨ÙŠØ© Ø§Ù„Ù…ØªØ­Ø¯Ø© - Ø±Ø¤Ù‰ Ø§Ù„Ø®Ø¨Ø±Ø§Ø¡', items: ['Ù…Ù‚Ø§Ø¨Ù„Ø§Øª Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ Ø§Ù„Ø§Ø³ØªØ´Ø§Ø±ÙŠÙŠÙ† ÙÙŠ Ø§Ù„Ù‚Ø·Ø§Ø¹ÙŠÙ† Ø§Ù„Ø¹Ø§Ù… ÙˆØ§Ù„Ø®Ø§Øµ', 'Ø¬Ù„Ø³Ø§Øª Ø§Ù„Ø®Ø¨Ø±Ø§Ø¡ Ø§Ù„Ø·Ø¨ÙŠÙŠÙ† ÙˆØ§Ù„Ù‚Ø§Ø¯Ø© Ø§Ù„Ø±Ø£ÙŠ KOL', 'Ù…Ø¬Ù…ÙˆØ¹Ø§Øª Ø§Ù„ØªØ±ÙƒÙŠØ² Ù…Ø¹ Ø§Ù„Ù…Ù‡Ù†ÙŠÙŠÙ† Ø§Ù„ØµØ­ÙŠÙŠÙ†', 'Ø¯Ø±Ø§Ø³Ø§Øª Ù…Ø³Ø§Ø±Ø§Øª Ø§Ù„Ø¹Ù„Ø§Ø¬ Ø¹Ø¨Ø± Ø§Ù„Ø­Ø¯ÙˆØ¯'] },
            { name: 'Ø§Ù„ÙƒÙˆÙŠØª ÙˆÙ‚Ø·Ø± - Ø§Ù„Ø¨Ø­Ø« Ø§Ù„Ù†ÙˆØ¹ÙŠ', items: ['Ù…Ù‚Ø§Ø¨Ù„Ø§Øª Ø§Ù„Ø®Ø¨Ø±Ø§Ø¡ Ø§Ù„Ø·Ø¨ÙŠÙŠÙ† ÙˆØ§Ù„Ø§Ø³ØªØ´Ø§Ø±ÙŠÙŠÙ†', 'Ù…Ø¬Ø§Ù„Ø³ Ø§Ø³ØªØ´Ø§Ø±ÙŠØ© Ù„Ù„Ø£Ø·Ø¨Ø§Ø¡', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ù†Ø¸Ø§Ù… Ø§Ù„ØµØ­ÙŠ ÙˆØ§Ù„Ø³ÙŠØ§Ø³Ø§Øª'] },
            { name: 'Ù…ØµØ± - Ø±Ø¤Ù‰ Ù…ØªØ¹Ù…Ù‚Ø©', items: ['Ù…Ù‚Ø§Ø¨Ù„Ø§Øª Ø£Ø³Ø§ØªØ°Ø© Ø§Ù„Ø¬Ø§Ù…Ø¹Ø§Øª ÙˆØ§Ù„Ø§Ø³ØªØ´Ø§Ø±ÙŠÙŠÙ†', 'Ù…Ø¬Ù…ÙˆØ¹Ø§Øª Ù†Ù‚Ø§Ø´ Ù…Ø¹ Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ Ø§Ù„Ù…ØªØ®ØµØµÙŠÙ†', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ù…Ù…Ø§Ø±Ø³Ø§Øª Ø§Ù„Ø·Ø¨ÙŠØ© Ø§Ù„Ø¥Ø«Ù†ÙˆØºØ±Ø§ÙÙŠØ©', 'ØªØ­Ù„ÙŠÙ„ ÙˆØ¬Ù‡Ø§Øª Ù†Ø¸Ø± Ø§Ù„Ù…Ø±Ø¶Ù‰ Ø§Ù„Ø«Ù‚Ø§ÙÙŠØ©'] },
            { name: 'Ø§Ù„Ù…ØºØ±Ø¨ ÙˆØ§Ù„Ø¬Ø²Ø§Ø¦Ø± ÙˆØªÙˆÙ†Ø³ - Ø§Ù„Ø¨Ø­Ø« Ø§Ù„Ù†ÙˆØ¹ÙŠ', items: ['Ù…Ù‚Ø§Ø¨Ù„Ø§Øª Ø§Ù„Ø®Ø¨Ø±Ø§Ø¡ Ø§Ù„Ø·Ø¨ÙŠÙŠÙ† ÙÙŠ Ø´Ù…Ø§Ù„ Ø£ÙØ±ÙŠÙ‚ÙŠØ§', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ù†Ø¸Ù… Ø§Ù„ØµØ­ÙŠØ© Ø§Ù„Ù…Ù‚Ø§Ø±Ù†Ø©', 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ø³ÙŠØ§Ù‚ Ø§Ù„Ø«Ù‚Ø§ÙÙŠ ÙˆØ§Ù„Ø§Ø¬ØªÙ…Ø§Ø¹ÙŠ'] },
            { name: 'Ø¥ÙŠØ±Ø§Ù† - Ø±Ø¤Ù‰ Ø§Ù„Ø®Ø¨Ø±Ø§Ø¡', items: ['Ù…Ù‚Ø§Ø¨Ù„Ø§Øª Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ ÙˆØ§Ù„Ø¨Ø§Ø­Ø«ÙŠÙ† Ø§Ù„Ø¥ÙŠØ±Ø§Ù†ÙŠÙŠÙ†', 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ø³ÙˆÙ‚ ÙˆØ§Ù„Ù†Ø¸Ø§Ù… Ø§Ù„ØµØ­ÙŠ', 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„ØªØµÙ†ÙŠØ¹ Ø§Ù„Ù…Ø­Ù„ÙŠ ÙˆØ§Ù„Ø§Ø¨ØªÙƒØ§Ø±'] },
          ],
          deliverables: 'Ø§Ù„Ù…Ø®Ø±Ø¬Ø§Øª: ØªÙ‚Ø§Ø±ÙŠØ± Ø§Ù„ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ù…ÙˆØ¶ÙˆØ¹ÙŠØŒ Ø±Ø¤Ù‰ Ø§Ù„Ù†Ø¸Ø§Ù… Ø§Ù„ØµØ­ÙŠØŒ Ù…Ù„Ø®ØµØ§Øª Ø¥Ø¬Ù…Ø§Ø¹ Ø§Ù„Ø®Ø¨Ø±Ø§Ø¡ØŒ ØªÙˆØµÙŠØ§Øª Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ© Ù„Ù„ÙˆØµÙˆÙ„ Ù„Ù„Ø³ÙˆÙ‚ØŒ Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ§Øª Ø§Ù„ØªÙØ§Ø¹Ù„ Ù…Ø¹ KOLØŒ ØªÙ‚ÙŠÙŠÙ…Ø§Øª Ø§Ù„Ø§Ø­ØªÙŠØ§Ø¬Ø§Øª ØºÙŠØ± Ø§Ù„Ù…Ù„Ø¨Ø§Ø©',
        },
      ],
      serviceSecondaryAr: [
        {
          title: 'Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ© Ø§Ù„ÙˆØµÙˆÙ„ Ù„Ù„Ø³ÙˆÙ‚ ÙˆØ¯Ø¹Ù… Ø§Ù„Ø§Ù‚ØªØµØ§Ø¯ Ø§Ù„ØµØ­ÙŠ',
          intro: 'Ø§Ù„Ø§Ø³ØªÙØ§Ø¯Ø© Ù…Ù† Ø±Ø¤Ù‰ Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ø³ÙˆÙ‚ Ø§Ù„Ø¹Ù…ÙŠÙ‚Ø© Ù„Ø¯Ø¹Ù… Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ§Øª Ø§Ù„ÙˆØµÙˆÙ„ Ù„Ù„Ø³ÙˆÙ‚ ÙˆØ§Ù„ØªØ³Ø¹ÙŠØ± ÙˆØ§Ù„Ø³Ø¯Ø§Ø¯ Ø¹Ø¨Ø± Ø£Ø³ÙˆØ§Ù‚ Ø§Ù„Ø®Ù„ÙŠØ¬ ÙˆØ§Ù„Ø´Ø±Ù‚ Ø§Ù„Ø£ÙˆØ³Ø·.',
          regions: [
            { name: 'Ø¯ÙˆÙ„ Ø§Ù„Ø®Ù„ÙŠØ¬ Ø§Ù„Ø¹Ø±Ø¨ÙŠ', items: ['ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ù…Ø´Ù‡Ø¯ Ø§Ù„ØªÙ†Ø¸ÙŠÙ…ÙŠ ÙˆØ§Ù„ØªØ³Ø¹ÙŠØ± (SFDAØŒ DHAØŒ MOH)', 'Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ© Ø§Ù„Ù…Ù†Ø§Ù‚ØµØ§Øª Ø§Ù„Ø­ÙƒÙˆÙ…ÙŠØ© ÙˆØ§Ù„ÙˆØµÙˆÙ„ Ù„Ù‚ÙˆØ§Ø¦Ù… Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª', 'Ø±Ø¤Ù‰ Ø£ØµØ­Ø§Ø¨ Ø§Ù„Ù…ØµÙ„Ø­Ø© Ø§Ù„Ø­ÙƒÙˆÙ…ÙŠÙŠÙ†', 'ØªØ·ÙˆÙŠØ± Ø¹Ø±Ø¶ Ø§Ù„Ù‚ÙŠÙ…Ø© ÙˆØ§Ù„Ø±Ø³Ø§Ø¦Ù„ Ø§Ù„ØªØ³ÙˆÙŠÙ‚ÙŠØ©'] },
            { name: 'Ù…ØµØ± ÙˆØ´Ù…Ø§Ù„ Ø£ÙØ±ÙŠÙ‚ÙŠØ§', items: ['Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ© Ø§Ù„ØªØ³Ø¹ÙŠØ± ÙˆØ§Ù„Ø³Ø¯Ø§Ø¯', 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„ØªØ£Ù…ÙŠÙ† Ø§Ù„ØµØ­ÙŠ ÙˆØ§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ', 'Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ø§Ù‚ØªØµØ§Ø¯ Ø§Ù„ØµØ­ÙŠ ÙˆØ§Ù„Ù†ØªØ§Ø¦Ø¬ (HEOR)'] },
          ],
          note: 'Ø®Ø¯Ù…Ø§ØªÙ†Ø§ ÙÙŠ Ø§Ù„ÙˆØµÙˆÙ„ Ù„Ù„Ø³ÙˆÙ‚ Ù‚Ø§Ø¦Ù…Ø© Ø¹Ù„Ù‰ Ø§Ù„Ø£Ø¨Ø­Ø§Ø«ØŒ Ø¨Ø§Ø³ØªØ®Ø¯Ø§Ù… Ø±Ø¤Ù‰ Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ØŒ Ø§Ù„Ø¬Ù‡Ø§Øª Ø§Ù„Ø¯Ø§ÙØ¹Ø©ØŒ ÙˆØ£ØµØ­Ø§Ø¨ Ø§Ù„Ù…ØµÙ„Ø­Ø© Ø§Ù„Ù…Ø¬Ù…Ø¹Ø© Ù…Ù† Ø®Ù„Ø§Ù„ Ù‚Ø¯Ø±Ø§ØªÙ†Ø§ Ø§Ù„Ø£Ø³Ø§Ø³ÙŠØ© ÙÙŠ Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ø³ÙˆÙ‚.',
        },
        {
          title: 'Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ø¬Ø¯ÙˆÙ‰ Ù„Ù„ØªØ¬Ø§Ø±Ø¨ Ø§Ù„Ø³Ø±ÙŠØ±ÙŠØ© ÙˆÙ…Ø¹Ù„ÙˆÙ…Ø§Øª Ø§Ù„Ù…ÙˆØ§Ù‚Ø¹ Ø§Ù„Ø¨Ø­Ø«ÙŠØ©',
          intro: 'Ø¯Ø¹Ù… Ø§Ù„ØªØ·ÙˆÙŠØ± Ø§Ù„Ø³Ø±ÙŠØ±ÙŠ Ø¨Ø±Ø¤Ù‰ Ø¨Ø­Ø«ÙŠØ© Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ© Ø­ÙˆÙ„ Ø¬Ø¯ÙˆÙ‰ Ø§Ù„ØªØ¬Ø§Ø±Ø¨ØŒ Ø§Ø®ØªÙŠØ§Ø± Ø§Ù„Ù…ÙˆØ§Ù‚Ø¹ØŒ ÙˆØ´Ø¨ÙƒØ§Øª Ø§Ù„Ø¨Ø§Ø­Ø«ÙŠÙ†.',
          regions: [
            { name: 'Ø®Ø¯Ù…Ø§Øª Ø£Ø¨Ø­Ø§Ø« Ø§Ù„ØªØ¬Ø§Ø±Ø¨ Ø§Ù„Ø³Ø±ÙŠØ±ÙŠØ©', items: ['Ø¯Ø±Ø§Ø³Ø§Øª Ø§Ù„Ø¬Ø¯ÙˆÙ‰ ÙˆØªØ­Ø¯ÙŠØ¯ Ø§Ù„Ù…ÙˆØ§Ù‚Ø¹ Ø§Ù„Ø¨Ø­Ø«ÙŠØ© ÙÙŠ Ø§Ù„Ø®Ù„ÙŠØ¬ ÙˆØ§Ù„Ø´Ø±Ù‚ Ø§Ù„Ø£ÙˆØ³Ø·', 'Ø±Ø³Ù… Ø®Ø±Ø§Ø¦Ø· Ø§Ù„Ø¨Ø§Ø­Ø«ÙŠÙ† ÙˆØªØ­Ø¯ÙŠØ¯ KOL', 'Ø±Ø¤Ù‰ ØªÙˆØ¸ÙŠÙ Ø§Ù„Ù…Ø±Ø¶Ù‰ ÙˆØªØ­Ø³ÙŠÙ† Ø§Ù„Ø¨Ø±ÙˆØªÙˆÙƒÙˆÙ„', 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ù…Ø´Ù‡Ø¯ Ø§Ù„ØªÙ†Ø§ÙØ³ÙŠ Ù„Ù„ØªØ¬Ø§Ø±Ø¨', 'ØªÙ‚ÙŠÙŠÙ… Ø£Ø¯Ø§Ø¡ ÙˆÙ‚Ø¯Ø±Ø§Øª Ø§Ù„Ù…ÙˆØ§Ù‚Ø¹'] },
          ],
          note: 'ØªØ³ØªÙÙŠØ¯ Ø®Ø¯Ù…Ø§Øª Ø§Ù„ØªØ¬Ø§Ø±Ø¨ Ø§Ù„Ø³Ø±ÙŠØ±ÙŠØ© Ù…Ù† Ø´Ø¨ÙƒØ§Øª Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ Ø§Ù„ÙˆØ§Ø³Ø¹Ø© ÙˆÙ…Ø¹Ø±ÙØªÙ†Ø§ Ø¨Ø§Ù„Ù†Ø¸Ø§Ù… Ø§Ù„ØµØ­ÙŠ Ù„Ø¯Ø¹Ù… Ø¨Ø±Ø§Ù…Ø¬ Ø§Ù„ØªØ·ÙˆÙŠØ± Ø§Ù„Ø³Ø±ÙŠØ±ÙŠ Ø§Ù„Ø®Ø§ØµØ© Ø¨Ùƒ.',
        },
      ],
      items: [
        {
          title: 'Ø§Ù„ÙˆØµÙˆÙ„ Ø¥Ù„Ù‰ Ø§Ù„Ø³ÙˆÙ‚ ÙˆØ§Ù„ØªØ³Ø¹ÙŠØ±',
          description: 'ØªÙ†Ù‚Ù„ ÙÙŠ Ù…Ø´Ù‡Ø¯ Ø§Ù„ØªØ¹ÙˆÙŠØ¶Ø§Øª Ø§Ù„Ù…Ø¹Ù‚Ø¯ Ø¨Ø§Ø³ØªØ®Ø¯Ø§Ù… Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ§Øª ØªØ³Ø¹ÙŠØ± Ù‚Ø§Ø¦Ù…Ø© Ø¹Ù„Ù‰ Ø§Ù„Ø£Ø¯Ù„Ø© ÙˆØ£Ø·Ø± Ø¥Ø´Ø±Ø§Ùƒ Ø§Ù„Ø¯Ø§ÙØ¹ÙŠÙ†.',
        },
        {
          title: 'Ø§Ù„Ø§Ø³ØªØ®Ø¨Ø§Ø±Ø§Øª Ø§Ù„ØªÙ†Ø§ÙØ³ÙŠØ©',
          description: 'Ø§Ø¨Ù‚ ÙÙŠ Ø§Ù„Ù…Ù‚Ø¯Ù…Ø© Ù…Ø¹ Ø§Ù„Ù…Ø±Ø§Ù‚Ø¨Ø© Ø§Ù„ØªÙ†Ø§ÙØ³ÙŠØ© ÙÙŠ Ø§Ù„ÙˆÙ‚Øª Ø§Ù„ÙØ¹Ù„ÙŠ ÙˆØªØ­Ù„ÙŠÙ„ Ø®Ø· Ø§Ù„Ø£Ù†Ø§Ø¨ÙŠØ¨ ÙˆØ±Ø¤Ù‰ Ø§Ù„Ù…ÙˆÙ‚Ø¹ Ø§Ù„Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠ.',
        },
      ],
    },
    insights: {
      title: 'Ø£Ø­Ø¯Ø« Ø§Ù„Ø±Ø¤Ù‰',
      subtitle: 'Ø§Ù„Ù‚ÙŠØ§Ø¯Ø© Ø§Ù„ÙÙƒØ±ÙŠØ© ÙˆÙˆØ¬Ù‡Ø§Øª Ù†Ø¸Ø± Ø§Ù„Ø¨Ø­Ø« Ù…Ù† ÙØ±ÙŠÙ‚Ù†Ø§ Ø§Ù„Ø¹Ø§Ù„Ù…ÙŠ',
      readMore: 'Ø§Ù‚Ø±Ø£ Ø§Ù„Ù…Ù‚Ø§Ù„',
      items: [
        {
          category: 'Ø§Ù„ÙˆØµÙˆÙ„ Ø¥Ù„Ù‰ Ø§Ù„Ø³ÙˆÙ‚',
          title: 'Ù…Ø³ØªÙ‚Ø¨Ù„ Ø§ØªÙØ§Ù‚ÙŠØ§Øª Ø§Ù„Ø±Ø¹Ø§ÙŠØ© Ø§Ù„ØµØ­ÙŠØ© Ø§Ù„Ù‚Ø§Ø¦Ù…Ø© Ø¹Ù„Ù‰ Ø§Ù„Ù‚ÙŠÙ…Ø© ÙÙŠ Ø£ÙˆØ±ÙˆØ¨Ø§',
          excerpt: 'ÙƒÙŠÙ ØªØ¹ÙŠØ¯ Ù†Ù…Ø§Ø°Ø¬ Ø§Ù„ØªØ¹Ø§Ù‚Ø¯ Ø§Ù„Ù…Ø¨ØªÙƒØ±Ø© ØªØ´ÙƒÙŠÙ„ Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ§Øª Ø§Ù„ØªØ³Ø¹ÙŠØ± ÙˆØ§Ù„ÙˆØµÙˆÙ„ Ø§Ù„ØµÙŠØ¯Ù„Ø§Ù†ÙŠ Ø¹Ø¨Ø± Ø§Ù„Ø£Ø³ÙˆØ§Ù‚ Ø§Ù„Ø£ÙˆØ±ÙˆØ¨ÙŠØ© Ø§Ù„Ø±Ø¦ÙŠØ³ÙŠØ©.',
          date: 'ØªÙ‚Ø±ÙŠØ± Ø§Ù„Ø±Ø¨Ø¹ Ø§Ù„Ø±Ø§Ø¨Ø¹ 2024',
        },
        {
          category: 'Ø§Ù„ØµØ­Ø© Ø§Ù„Ø±Ù‚Ù…ÙŠØ©',
          title: 'Ø§ÙƒØªØ´Ø§Ù Ø§Ù„Ø£Ø¯ÙˆÙŠØ© Ø¨Ø§Ù„Ø°ÙƒØ§Ø¡ Ø§Ù„Ø§ØµØ·Ù†Ø§Ø¹ÙŠ: ØªØ¯Ø§Ø¹ÙŠØ§Øª Ø§Ù„Ø³ÙˆÙ‚',
          excerpt: 'ØªØ­Ù„ÙŠÙ„ ØªØ­ÙˆÙ„ Ø§Ù„Ù…Ø´Ù‡Ø¯ Ø§Ù„ØªÙ†Ø§ÙØ³ÙŠ Ø¨ÙŠÙ†Ù…Ø§ ÙŠØ­ÙˆÙ„ Ø§Ù„Ø°ÙƒØ§Ø¡ Ø§Ù„Ø§ØµØ·Ù†Ø§Ø¹ÙŠ Ø§Ù„Ø¨Ø­Ø« ÙˆØ§Ù„ØªØ·ÙˆÙŠØ± Ø§Ù„ØµÙŠØ¯Ù„Ø§Ù†ÙŠ ÙˆÙˆÙ‚Øª Ø§Ù„ÙˆØµÙˆÙ„ Ø¥Ù„Ù‰ Ø§Ù„Ø³ÙˆÙ‚.',
          date: 'Ù…ÙˆØ¬Ø² Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠ',
        },
        {
          category: 'Ø§Ù„Ø£ÙˆØ±Ø§Ù…',
          title: 'Ø¯ÙŠÙ†Ø§Ù…ÙŠÙƒÙŠØ§Øª Ø³ÙˆÙ‚ Ø§Ù„Ø·Ø¨ Ø§Ù„Ø¯Ù‚ÙŠÙ‚ 2025',
          excerpt: 'ØªØ­Ù„ÙŠÙ„ Ø´Ø§Ù…Ù„ Ù„Ù„Ø¹Ù„Ø§Ø¬Ø§Øª Ø§Ù„Ù…ÙˆØ¬Ù‡Ø© Ø¨Ø§Ù„Ù…Ø¤Ø´Ø±Ø§Øª Ø§Ù„Ø­ÙŠÙˆÙŠØ© ÙˆÙ†Ù…ÙˆØ°Ø¬ Ø¹Ù„Ø§Ø¬ Ø§Ù„Ø£ÙˆØ±Ø§Ù… Ø§Ù„Ù…ØªØ·ÙˆØ±.',
          date: 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„ØµÙ†Ø§Ø¹Ø©',
        },
      ],
    },
    blog: {
      title: 'Ø£Ø­Ø¯Ø« Ø§Ù„Ø±Ø¤Ù‰',
      subtitle: 'Ø§Ù„Ù‚ÙŠØ§Ø¯Ø© Ø§Ù„ÙÙƒØ±ÙŠØ© ÙˆÙˆØ¬Ù‡Ø§Øª Ù†Ø¸Ø± Ø§Ù„Ø¨Ø­Ø« Ù…Ù† ÙØ±ÙŠÙ‚Ù†Ø§ Ø§Ù„Ø¹Ø§Ù„Ù…ÙŠ',
      readMore: 'Ø§Ù‚Ø±Ø£ Ø§Ù„Ù…Ù‚Ø§Ù„',
      readMoreArticles: 'Ø§Ù‚Ø±Ø£ Ø§Ù„Ù…Ø²ÙŠØ¯ Ù…Ù† Ø§Ù„Ù…Ù‚Ø§Ù„Ø§Øª',
      filterAllTopics: 'Ø¬Ù…ÙŠØ¹ Ø§Ù„Ù…ÙˆØ§Ø¶ÙŠØ¹',
      filterAllCountries: 'Ø¬Ù…ÙŠØ¹ Ø§Ù„Ø¨Ù„Ø¯Ø§Ù†',
      filterByTopic: 'Ø§Ù„Ù…ÙˆØ¶ÙˆØ¹',
      filterByCountry: 'Ø§Ù„Ø¨Ù„Ø¯',
      items: [
        { category: 'Ø§Ù„ÙˆØµÙˆÙ„ Ø¥Ù„Ù‰ Ø§Ù„Ø³ÙˆÙ‚', country: 'Ø£ÙˆØ±ÙˆØ¨Ø§', title: 'Ù…Ø³ØªÙ‚Ø¨Ù„ Ø§ØªÙØ§Ù‚ÙŠØ§Øª Ø§Ù„Ø±Ø¹Ø§ÙŠØ© Ø§Ù„ØµØ­ÙŠØ© Ø§Ù„Ù‚Ø§Ø¦Ù…Ø© Ø¹Ù„Ù‰ Ø§Ù„Ù‚ÙŠÙ…Ø© ÙÙŠ Ø£ÙˆØ±ÙˆØ¨Ø§', excerpt: 'ÙƒÙŠÙ ØªØ¹ÙŠØ¯ Ù†Ù…Ø§Ø°Ø¬ Ø§Ù„ØªØ¹Ø§Ù‚Ø¯ Ø§Ù„Ù…Ø¨ØªÙƒØ±Ø© ØªØ´ÙƒÙŠÙ„ Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ§Øª Ø§Ù„ØªØ³Ø¹ÙŠØ± ÙˆØ§Ù„ÙˆØµÙˆÙ„ Ø§Ù„ØµÙŠØ¯Ù„Ø§Ù†ÙŠ Ø¹Ø¨Ø± Ø§Ù„Ø£Ø³ÙˆØ§Ù‚ Ø§Ù„Ø£ÙˆØ±ÙˆØ¨ÙŠØ© Ø§Ù„Ø±Ø¦ÙŠØ³ÙŠØ©.', date: 'ØªÙ‚Ø±ÙŠØ± Ø§Ù„Ø±Ø¨Ø¹ Ø§Ù„Ø±Ø§Ø¨Ø¹ 2024' },
        { category: 'Ø§Ù„ØµØ­Ø© Ø§Ù„Ø±Ù‚Ù…ÙŠØ©', country: 'Ø§Ù„ÙˆÙ„Ø§ÙŠØ§Øª Ø§Ù„Ù…ØªØ­Ø¯Ø©', title: 'Ø§ÙƒØªØ´Ø§Ù Ø§Ù„Ø£Ø¯ÙˆÙŠØ© Ø¨Ø§Ù„Ø°ÙƒØ§Ø¡ Ø§Ù„Ø§ØµØ·Ù†Ø§Ø¹ÙŠ: ØªØ¯Ø§Ø¹ÙŠØ§Øª Ø§Ù„Ø³ÙˆÙ‚', excerpt: 'ØªØ­Ù„ÙŠÙ„ ØªØ­ÙˆÙ„ Ø§Ù„Ù…Ø´Ù‡Ø¯ Ø§Ù„ØªÙ†Ø§ÙØ³ÙŠ Ø¨ÙŠÙ†Ù…Ø§ ÙŠØ­ÙˆÙ„ Ø§Ù„Ø°ÙƒØ§Ø¡ Ø§Ù„Ø§ØµØ·Ù†Ø§Ø¹ÙŠ Ø§Ù„Ø¨Ø­Ø« ÙˆØ§Ù„ØªØ·ÙˆÙŠØ± Ø§Ù„ØµÙŠØ¯Ù„Ø§Ù†ÙŠ ÙˆÙˆÙ‚Øª Ø§Ù„ÙˆØµÙˆÙ„ Ø¥Ù„Ù‰ Ø§Ù„Ø³ÙˆÙ‚.', date: 'Ù…ÙˆØ¬Ø² Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠ' },
        { category: 'Ø§Ù„Ø£ÙˆØ±Ø§Ù…', country: 'Ø§Ù„Ù…Ù…Ù„ÙƒØ© Ø§Ù„Ù…ØªØ­Ø¯Ø©', title: 'Ø¯ÙŠÙ†Ø§Ù…ÙŠÙƒÙŠØ§Øª Ø³ÙˆÙ‚ Ø§Ù„Ø·Ø¨ Ø§Ù„Ø¯Ù‚ÙŠÙ‚ 2025', excerpt: 'ØªØ­Ù„ÙŠÙ„ Ø´Ø§Ù…Ù„ Ù„Ù„Ø¹Ù„Ø§Ø¬Ø§Øª Ø§Ù„Ù…ÙˆØ¬Ù‡Ø© Ø¨Ø§Ù„Ù…Ø¤Ø´Ø±Ø§Øª Ø§Ù„Ø­ÙŠÙˆÙŠØ© ÙˆÙ†Ù…ÙˆØ°Ø¬ Ø¹Ù„Ø§Ø¬ Ø§Ù„Ø£ÙˆØ±Ø§Ù… Ø§Ù„Ù…ØªØ·ÙˆØ±.', date: 'ØªØ­Ù„ÙŠÙ„ Ø§Ù„ØµÙ†Ø§Ø¹Ø©' },
      ],
    },
    stats: {
      title: 'Ø§Ù„ØªØ£Ø«ÙŠØ± Ø§Ù„Ø¹Ø§Ù„Ù…ÙŠ',
      items: [
        { value: '+50', label: 'Ø¯ÙˆÙ„Ø© Ù…ØºØ·Ø§Ø©' },
        { value: '+10', label: 'Ø´Ø±ÙƒØ§Ø¡ Ù†Ø¬Ø§Ø­' },
        { value: '+120', label: 'Ù…Ø´Ø±ÙˆØ¹ Ù…Ù†Ø¬Ø²' },
        { value: '+15', label: 'Ø³Ù†Ø© Ø®Ø¨Ø±Ø©' },
      ],
    },
    testimonials: {
      title: 'Ø¢Ø±Ø§Ø¡ Ø§Ù„Ø¹Ù…Ù„Ø§Ø¡',
      subtitle: 'Ù…ÙˆØ«ÙˆÙ‚ Ø¨Ù‡ Ù…Ù† Ù‚Ø¨Ù„ Ø´Ø±ÙƒØ§Øª Ø§Ù„Ø£Ø¯ÙˆÙŠØ© ÙˆØ§Ù„ØªÙƒÙ†ÙˆÙ„ÙˆØ¬ÙŠØ§ Ø§Ù„Ø­ÙŠÙˆÙŠØ© Ø§Ù„Ø±Ø§Ø¦Ø¯Ø© ÙÙŠ Ø¬Ù…ÙŠØ¹ Ø£Ù†Ø­Ø§Ø¡ Ø§Ù„Ø¹Ø§Ù„Ù…',
    },
    contact: {
      title: 'Ù„Ù†ØªÙˆØ§ØµÙ„',
      subtitle: 'Ù‡Ù„ Ø£Ù†Øª Ù…Ø³ØªØ¹Ø¯ Ù„ØªØ­ÙˆÙŠÙ„ Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ© Ø³ÙˆÙ‚ Ø§Ù„Ø±Ø¹Ø§ÙŠØ© Ø§Ù„ØµØ­ÙŠØ© Ø§Ù„Ø®Ø§ØµØ© Ø¨ÙƒØŸ ÙØ±ÙŠÙ‚ Ø®Ø¨Ø±Ø§Ø¦Ù†Ø§ Ù‡Ù†Ø§ Ù„Ù„Ù…Ø³Ø§Ø¹Ø¯Ø©.',
      cta: 'Ø­Ø¯Ø¯ Ù…ÙˆØ¹Ø¯ Ø§Ø³ØªØ´Ø§Ø±Ø©',
      email: 'admin@bionixus.com',
      headquarters: 'Wyoming, USA',
    },
    localePrompt: {
      title: 'Ø£Ù†Øª ØªÙØªØ­ Ù…Ù† {region}.',
      question: 'Ù‡Ù„ ØªØ±ÙŠØ¯ Ø§Ù„ØªØ¨Ø¯ÙŠÙ„ Ø¥Ù„Ù‰ {language}ØŸ',
      yes: 'Ù†Ø¹Ù…',
      no: 'Ù„Ø§',
    },
    footer: {
      tagline: 'Ø§Ù„Ø°ÙƒØ§Ø¡ Ø§Ù„Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠ Ù„Ù„Ø±Ø¹Ø§ÙŠØ© Ø§Ù„ØµØ­ÙŠØ©',
      copyright: 'Â© 2024 Ø¨ÙŠÙˆÙ†ÙŠÙƒØ³Ø³. Ø¬Ù…ÙŠØ¹ Ø§Ù„Ø­Ù‚ÙˆÙ‚ Ù…Ø­ÙÙˆØ¸Ø©.',
      privacy: 'Ø³ÙŠØ§Ø³Ø© Ø§Ù„Ø®ØµÙˆØµÙŠØ©',
      terms: 'Ø´Ø±ÙˆØ· Ø§Ù„Ø®Ø¯Ù…Ø©',
    },
    cookieConsent: {
      message: 'Ù†Ø³ØªØ®Ø¯Ù… Ù…Ù„ÙØ§Øª ØªØ¹Ø±ÙŠÙ Ø§Ù„Ø§Ø±ØªØ¨Ø§Ø· Ù„ØªØ­Ø³ÙŠÙ† ØªØ¬Ø±Ø¨ØªÙƒ ÙˆØªØ­Ù„ÙŠÙ„ Ø­Ø±ÙƒØ© Ø§Ù„Ù…ÙˆÙ‚Ø¹. Ø¨Ø§Ù„Ù†Ù‚Ø± Ø¹Ù„Ù‰ Ù‚Ø¨ÙˆÙ„ ÙØ¥Ù†Ùƒ ØªÙˆØ§ÙÙ‚ Ø¹Ù„Ù‰ Ø§Ø³ØªØ®Ø¯Ø§Ù…Ù†Ø§ Ù„Ù…Ù„ÙØ§Øª ØªØ¹Ø±ÙŠÙ Ø§Ù„Ø§Ø±ØªØ¨Ø§Ø· ÙˆØ³ÙŠØ§Ø³Ø© Ø§Ù„Ø®ØµÙˆØµÙŠØ©.',
      accept: 'Ù‚Ø¨ÙˆÙ„',
      decline: 'Ø±ÙØ¶',
      privacyLink: 'Ø³ÙŠØ§Ø³Ø© Ø§Ù„Ø®ØµÙˆØµÙŠØ©',
    },
    geographicCoverageAr: {
      title: 'Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ø³ÙˆÙ‚ Ø§Ù„ØµØ­ÙŠØ© Ø¹Ø¨Ø± Ø¯ÙˆÙ„ Ø§Ù„Ø®Ù„ÙŠØ¬ ÙˆØ§Ù„Ø´Ø±Ù‚ Ø§Ù„Ø£ÙˆØ³Ø·',
      countries: [
        {
          name: 'Ø§Ù„Ù…Ù…Ù„ÙƒØ© Ø§Ù„Ø¹Ø±Ø¨ÙŠØ© Ø§Ù„Ø³Ø¹ÙˆØ¯ÙŠØ© - Ù…Ø±ÙƒØ² Ø§Ù„Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ø¯ÙˆØ§Ø¦ÙŠØ©',
          featured: true,
          marketSize: 'Ø£ÙƒØ¨Ø± Ø³ÙˆÙ‚ Ø¯ÙˆØ§Ø¦ÙŠ ÙÙŠ Ù…Ù†Ø·Ù‚Ø© Ø§Ù„Ø®Ù„ÙŠØ¬',
          sections: [
            { heading: 'Ø§Ù„ØªØºØ·ÙŠØ© Ø§Ù„Ø¬ØºØ±Ø§ÙÙŠØ©', items: ['Ø§Ù„Ø±ÙŠØ§Ø¶: Ù…Ø³ØªØ´ÙÙŠØ§Øª ÙˆØ²Ø§Ø±Ø© Ø§Ù„ØµØ­Ø©ØŒ Ø§Ù„Ù…Ø¯Ù† Ø§Ù„Ø·Ø¨ÙŠØ©ØŒ Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ', 'Ø¬Ø¯Ø©: Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø¬Ø§Ù…Ø¹ÙŠØ©ØŒ Ø§Ù„Ù…Ø±Ø§ÙƒØ² Ø§Ù„ØªØ®ØµØµÙŠØ©', 'Ø§Ù„Ø¯Ù…Ø§Ù… ÙˆØ§Ù„Ù…Ù†Ø·Ù‚Ø© Ø§Ù„Ø´Ø±Ù‚ÙŠØ©: Ø§Ù„Ù…Ø¬Ù…Ø¹Ø§Øª Ø§Ù„Ø·Ø¨ÙŠØ©', 'Ø§Ù„Ù…Ø¯ÙŠÙ†Ø© Ø§Ù„Ù…Ù†ÙˆØ±Ø©ØŒ Ù…ÙƒØ© Ø§Ù„Ù…ÙƒØ±Ù…Ø©ØŒ Ø£Ø¨Ù‡Ø§: Ø§Ù„ØªØºØ·ÙŠØ© Ø§Ù„Ø¥Ù‚Ù„ÙŠÙ…ÙŠØ©'] },
            { heading: 'Ø§Ù„Ù…Ø¤Ø³Ø³Ø§Øª Ø§Ù„ØµØ­ÙŠØ© Ø§Ù„Ø±Ø¦ÙŠØ³ÙŠØ©', items: ['ÙˆØ²Ø§Ø±Ø© Ø§Ù„ØµØ­Ø© - Ø´Ø¨ÙƒØ© Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø­ÙƒÙˆÙ…ÙŠØ©', 'Ù…Ø¯ÙŠÙ†Ø© Ø§Ù„Ù…Ù„Ùƒ ÙÙ‡Ø¯ Ø§Ù„Ø·Ø¨ÙŠØ©', 'Ù…Ø¬Ù…Ø¹ Ø§Ù„Ù…Ù„Ùƒ Ø¹Ø¨Ø¯Ø§Ù„Ù„Ù‡ Ø§Ù„Ø·Ø¨ÙŠ', 'Ù…Ø³ØªØ´ÙÙ‰ Ø§Ù„Ù…Ù„Ùƒ ÙÙŠØµÙ„ Ø§Ù„ØªØ®ØµØµÙŠ', 'Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ: Ù…Ø³ØªØ´ÙÙ‰ Ø§Ù„Ù…Ù…Ù„ÙƒØ©ØŒ Ø³Ù„ÙŠÙ…Ø§Ù† Ø§Ù„Ø­Ø¨ÙŠØ¨ØŒ Ø¯Ù„Ù‡'] },
            { heading: 'Ø§Ù„ØªØ®ØµØµØ§Øª Ø§Ù„Ø¨Ø­Ø«ÙŠØ©', text: 'Ø§Ù„Ø³ÙƒØ±ÙŠØŒ Ø§Ù„Ù‚Ù„Ø¨ ÙˆØ§Ù„Ø£ÙˆØ¹ÙŠØ© Ø§Ù„Ø¯Ù…ÙˆÙŠØ©ØŒ Ø§Ù„Ø£ÙˆØ±Ø§Ù…ØŒ Ø§Ù„Ø£Ù…Ø±Ø§Ø¶ Ø§Ù„Ù†Ø§Ø¯Ø±Ø©ØŒ Ø·Ø¨ Ø§Ù„Ø£Ø·ÙØ§Ù„ØŒ ØµØ­Ø© Ø§Ù„Ù…Ø±Ø£Ø©' },
            { heading: 'Ø§Ù„Ø§Ù…ØªØ«Ø§Ù„ Ø§Ù„ØªÙ†Ø¸ÙŠÙ…ÙŠ', text: 'Ù…ØªÙˆØ§ÙÙ‚ Ù…Ø¹ Ù‡ÙŠØ¦Ø© Ø§Ù„ØºØ°Ø§Ø¡ ÙˆØ§Ù„Ø¯ÙˆØ§Ø¡ Ø§Ù„Ø³Ø¹ÙˆØ¯ÙŠØ© (SFDA) ÙˆÙˆØ²Ø§Ø±Ø© Ø§Ù„ØµØ­Ø©' },
          ],
        },
        {
          name: 'Ø§Ù„Ø¥Ù…Ø§Ø±Ø§Øª Ø§Ù„Ø¹Ø±Ø¨ÙŠØ© Ø§Ù„Ù…ØªØ­Ø¯Ø© - Ù…Ø±ÙƒØ² Ø§Ù„Ø§Ø¨ØªÙƒØ§Ø± Ø§Ù„ØµØ­ÙŠ',
          featured: true,
          marketSize: 'Ø³ÙˆÙ‚ ØµØ­ÙŠ Ù…ØªÙ‚Ø¯Ù… Ù…Ø¹ Ø³ÙŠØ§Ø­Ø© Ø¹Ù„Ø§Ø¬ÙŠØ©',
          sections: [
            { heading: 'Ø§Ù„ØªØºØ·ÙŠØ© Ø§Ù„Ø¬ØºØ±Ø§ÙÙŠØ©', items: ['Ø¯Ø¨ÙŠ: Ù…Ø¯ÙŠÙ†Ø© Ø¯Ø¨ÙŠ Ø§Ù„Ø·Ø¨ÙŠØ©ØŒ Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ', 'Ø£Ø¨ÙˆØ¸Ø¨ÙŠ: Ù…Ø³ØªØ´ÙÙ‰ ÙƒÙ„ÙŠÙÙ„Ø§Ù†Ø¯ ÙƒÙ„ÙŠÙ†ÙƒØŒ Ù…Ø¯ÙŠÙ†Ø© Ø§Ù„Ø´ÙŠØ® Ø®Ù„ÙŠÙØ© Ø§Ù„Ø·Ø¨ÙŠØ©', 'Ø§Ù„Ø´Ø§Ø±Ù‚Ø© ÙˆØ§Ù„Ø¥Ù…Ø§Ø±Ø§Øª Ø§Ù„Ø´Ù…Ø§Ù„ÙŠØ©: Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø¥Ù‚Ù„ÙŠÙ…ÙŠØ©'] },
            { heading: 'Ø§Ù„Ù…Ø¤Ø³Ø³Ø§Øª Ø§Ù„ØµØ­ÙŠØ© Ø§Ù„Ø±Ø¦ÙŠØ³ÙŠØ©', items: ['Ù‡ÙŠØ¦Ø© Ø§Ù„ØµØ­Ø© Ø¨Ø¯Ø¨ÙŠ (DHA)', 'Ø¯Ø§Ø¦Ø±Ø© Ø§Ù„ØµØ­Ø© Ø£Ø¨ÙˆØ¸Ø¨ÙŠ (DOH)', 'Ù…Ø³ØªØ´ÙÙ‰ ÙƒÙ„ÙŠÙÙ„Ø§Ù†Ø¯ ÙƒÙ„ÙŠÙ†Ùƒ Ø£Ø¨ÙˆØ¸Ø¨ÙŠ', 'Ù…Ø³ØªØ´ÙÙ‰ Ø§Ù„Ø¬Ù„ÙŠÙ„Ø© Ø§Ù„ØªØ®ØµØµÙŠ Ù„Ù„Ø£Ø·ÙØ§Ù„', 'Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ: NMCØŒ Ù…ÙŠØ¯ÙƒÙŠØ±ØŒ Ø¨Ø±Ø¬ÙŠÙ„'] },
            { heading: 'Ø§Ù„ØªØ®ØµØµØ§Øª Ø§Ù„Ø¨Ø­Ø«ÙŠØ©', text: 'Ø§Ù„Ø£ÙˆØ±Ø§Ù…ØŒ Ø§Ù„Ù‚Ù„Ø¨ØŒ Ø§Ù„Ø¬Ø±Ø§Ø­Ø© Ø§Ù„ØªØ®ØµØµÙŠØ©ØŒ Ø§Ù„Ø·Ø¨ Ø§Ù„ØªØ¬Ø¯ÙŠØ¯ÙŠØŒ Ø§Ù„Ø£Ù…Ø±Ø§Ø¶ Ø§Ù„Ø§Ø³ØªÙ‚Ù„Ø§Ø¨ÙŠØ©' },
          ],
        },
        {
          name: 'Ø§Ù„ÙƒÙˆÙŠØª - Ù†Ø¸Ø§Ù… ØµØ­ÙŠ Ù…ØªÙ‚Ø¯Ù…',
          featured: false,
          sections: [
            { heading: 'Ø§Ù„ØªØºØ·ÙŠØ©', items: ['Ù…Ø³ØªØ´ÙÙŠØ§Øª ÙˆØ²Ø§Ø±Ø© Ø§Ù„ØµØ­Ø©', 'Ø§Ù„Ù…Ø¬Ù…Ø¹Ø§Øª Ø§Ù„Ø·Ø¨ÙŠØ© Ø§Ù„ØªØ®ØµØµÙŠØ©', 'Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ ÙˆØ§Ù„Ø¹ÙŠØ§Ø¯Ø§Øª'] },
            { heading: 'Ø§Ù„ØªØ®ØµØµØ§Øª Ø§Ù„Ø¨Ø­Ø«ÙŠØ©', text: 'Ø§Ù„Ø³ÙƒØ±ÙŠØŒ Ø£Ù…Ø±Ø§Ø¶ Ø§Ù„Ù‚Ù„Ø¨ØŒ Ø¬Ø±Ø§Ø­Ø© Ø§Ù„Ø³Ù…Ù†Ø©ØŒ Ø§Ù„Ø£Ù…Ø±Ø§Ø¶ Ø§Ù„Ù…Ø²Ù…Ù†Ø©' },
          ],
        },
        {
          name: 'Ù‚Ø·Ø± - Ø§Ù„ØªÙ…ÙŠØ² Ø§Ù„Ø·Ø¨ÙŠ',
          featured: false,
          sections: [
            { heading: 'Ø§Ù„Ù…Ø¤Ø³Ø³Ø§Øª Ø§Ù„Ø±Ø¦ÙŠØ³ÙŠØ©', items: ['Ù…Ø¤Ø³Ø³Ø© Ø­Ù…Ø¯ Ø§Ù„Ø·Ø¨ÙŠØ©', 'Ø³Ø¯Ø±Ø© Ù„Ù„Ø·Ø¨', 'Ù…Ø³ØªØ´ÙÙ‰ Ø§Ù„Ø¹Ù…Ø§Ø¯ÙŠ', 'Ø§Ù„Ù…Ø±Ø§ÙƒØ² Ø§Ù„Ø·Ø¨ÙŠØ© Ø§Ù„ØªØ®ØµØµÙŠØ©'] },
            { heading: 'Ø§Ù„ØªØ®ØµØµØ§Øª Ø§Ù„Ø¨Ø­Ø«ÙŠØ©', text: 'Ø·Ø¨ Ø§Ù„Ø£Ø·ÙØ§Ù„ØŒ ØµØ­Ø© Ø§Ù„Ù…Ø±Ø£Ø©ØŒ Ø§Ù„Ø£ÙˆØ±Ø§Ù…ØŒ Ø§Ù„Ø·Ø¨ Ø§Ù„Ø±ÙŠØ§Ø¶ÙŠ' },
          ],
        },
        {
          name: 'Ù…ØµØ± - Ø£ÙƒØ¨Ø± Ø³ÙˆÙ‚ ÙÙŠ Ø´Ù…Ø§Ù„ Ø£ÙØ±ÙŠÙ‚ÙŠØ§',
          featured: true,
          marketSize: '100+ Ù…Ù„ÙŠÙˆÙ† Ù†Ø³Ù…Ø©ØŒ Ø³ÙˆÙ‚ Ø¯ÙˆØ§Ø¦ÙŠ Ù…ØªÙ†Ø§Ù…ÙŠ',
          sections: [
            { heading: 'Ø§Ù„ØªØºØ·ÙŠØ© Ø§Ù„Ø¬ØºØ±Ø§ÙÙŠØ©', items: ['Ø§Ù„Ù‚Ø§Ù‡Ø±Ø© Ø§Ù„ÙƒØ¨Ø±Ù‰: Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø¬Ø§Ù…Ø¹ÙŠØ©ØŒ Ø§Ù„Ù…Ø±Ø§ÙƒØ² Ø§Ù„ØªØ®ØµØµÙŠØ©', 'Ø§Ù„Ø¥Ø³ÙƒÙ†Ø¯Ø±ÙŠØ©: Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø¬Ø§Ù…Ø¹ÙŠØ© ÙˆØ®Ø§ØµØ©', 'Ø§Ù„Ø¯Ù„ØªØ§ ÙˆØ§Ù„ØµØ¹ÙŠØ¯: Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø¥Ù‚Ù„ÙŠÙ…ÙŠØ©'] },
            { heading: 'Ø§Ù„Ù…Ø¤Ø³Ø³Ø§Øª Ø§Ù„ØµØ­ÙŠØ©', items: ['Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø¬Ø§Ù…Ø¹Ø© Ø§Ù„Ù‚Ø§Ù‡Ø±Ø© ÙˆØ¹ÙŠÙ† Ø´Ù…Ø³', 'Ø§Ù„Ù…Ø¹Ù‡Ø¯ Ø§Ù„Ù‚ÙˆÙ…ÙŠ Ù„Ù„Ø£ÙˆØ±Ø§Ù…', 'Ù…Ø¹Ù‡Ø¯ Ø§Ù„Ù‚Ù„Ø¨ Ø§Ù„Ù‚ÙˆÙ…ÙŠ', 'Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ: Ø¯Ø§Ø± Ø§Ù„ÙØ¤Ø§Ø¯ØŒ Ø§Ù„Ø³Ø¹ÙˆØ¯ÙŠ Ø§Ù„Ø£Ù„Ù…Ø§Ù†ÙŠØŒ ÙƒÙ„ÙŠÙˆØ¨Ø§ØªØ±Ø§'] },
            { heading: 'Ø§Ù„ØªØ®ØµØµØ§Øª Ø§Ù„Ø¨Ø­Ø«ÙŠØ©', text: 'Ø§Ù„Ø£ÙˆØ±Ø§Ù…ØŒ Ø§Ù„Ù‚Ù„Ø¨ ÙˆØ§Ù„Ø£ÙˆØ¹ÙŠØ© Ø§Ù„Ø¯Ù…ÙˆÙŠØ©ØŒ Ø§Ù„Ø³ÙƒØ±ÙŠØŒ Ø§Ù„ÙƒØ¨Ø¯ØŒ Ø§Ù„Ø£Ù…Ø±Ø§Ø¶ Ø§Ù„Ù…Ø¹Ø¯ÙŠØ©ØŒ ØµØ­Ø© Ø§Ù„Ø£Ù… ÙˆØ§Ù„Ø·ÙÙ„' },
            { heading: 'Ø§Ù„Ø§Ù…ØªØ«Ø§Ù„', text: 'Ù…ØªÙˆØ§ÙÙ‚ Ù…Ø¹ Ù‡ÙŠØ¦Ø© Ø§Ù„Ø¯ÙˆØ§Ø¡ Ø§Ù„Ù…ØµØ±ÙŠØ© ÙˆÙˆØ²Ø§Ø±Ø© Ø§Ù„ØµØ­Ø©' },
          ],
        },
        {
          name: 'Ø§Ù„Ù…ØºØ±Ø¨ - Ø³ÙˆÙ‚ Ø´Ù…Ø§Ù„ Ø£ÙØ±ÙŠÙ‚ÙŠØ§ Ø§Ù„Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠ',
          featured: false,
          sections: [
            { heading: 'Ø§Ù„ØªØºØ·ÙŠØ© Ø§Ù„Ø¬ØºØ±Ø§ÙÙŠØ©', items: ['Ø§Ù„Ø¯Ø§Ø± Ø§Ù„Ø¨ÙŠØ¶Ø§Ø¡: Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø¬Ø§Ù…Ø¹ÙŠØ© CHUØŒ Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø®Ø§Øµ', 'Ø§Ù„Ø±Ø¨Ø§Ø·: Ø§Ù„Ù…Ø±Ø§ÙƒØ² Ø§Ù„Ø·Ø¨ÙŠØ© Ø§Ù„Ø­ÙƒÙˆÙ…ÙŠØ©', 'Ù…Ø±Ø§ÙƒØ´ØŒ ÙØ§Ø³ØŒ Ø·Ù†Ø¬Ø©: Ø§Ù„ØªØºØ·ÙŠØ© Ø§Ù„Ø¥Ù‚Ù„ÙŠÙ…ÙŠØ©'] },
            { heading: 'Ø§Ù„ØªØ®ØµØµØ§Øª Ø§Ù„Ø¨Ø­Ø«ÙŠØ©', text: 'Ø§Ù„Ø£ÙˆØ±Ø§Ù…ØŒ Ø£Ù…Ø±Ø§Ø¶ Ø§Ù„Ù‚Ù„Ø¨ØŒ Ø§Ù„Ø³ÙƒØ±ÙŠØŒ Ø§Ù„Ø£Ù…Ø±Ø§Ø¶ Ø§Ù„Ù…Ø¹Ø¯ÙŠØ©' },
          ],
        },
        {
          name: 'Ø§Ù„Ø¬Ø²Ø§Ø¦Ø± - Ø³ÙˆÙ‚ Ù…ØªÙ†Ø§Ù…ÙŠ',
          featured: false,
          sections: [
            { heading: 'Ø§Ù„ØªØºØ·ÙŠØ©', items: ['Ø§Ù„Ø¬Ø²Ø§Ø¦Ø± Ø§Ù„Ø¹Ø§ØµÙ…Ø©ØŒ ÙˆÙ‡Ø±Ø§Ù†ØŒ Ù‚Ø³Ù†Ø·ÙŠÙ†Ø©', 'Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø¬Ø§Ù…Ø¹ÙŠØ© CHU', 'Ø§Ù„Ù‚Ø·Ø§Ø¹ Ø§Ù„Ø¹Ø§Ù… ÙˆØ§Ù„Ø®Ø§Øµ'] },
          ],
        },
        {
          name: 'ØªÙˆÙ†Ø³ - Ù…Ø±ÙƒØ² Ø·Ø¨ÙŠ Ø¥Ù‚Ù„ÙŠÙ…ÙŠ',
          featured: false,
          sections: [
            { heading: 'Ø§Ù„ØªØºØ·ÙŠØ©', items: ['ØªÙˆÙ†Ø³ Ø§Ù„Ø¹Ø§ØµÙ…Ø©ØŒ ØµÙØ§Ù‚Ø³ØŒ Ø³ÙˆØ³Ø©', 'Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø¬Ø§Ù…Ø¹ÙŠØ©', 'Ø§Ù„Ø¹ÙŠØ§Ø¯Ø§Øª Ø§Ù„ØªØ®ØµØµÙŠØ©'] },
          ],
        },
      ],
    },
    methodologyAr: {
      title: 'Ù…Ù†Ù‡Ø¬ÙŠØ© Ø£Ø¨Ø­Ø§Ø« Ø§Ù„Ø³ÙˆÙ‚ Ø§Ù„ØµØ­ÙŠØ© Ø§Ù„Ù‚Ø§Ø¦Ù…Ø© Ø¹Ù„Ù‰ Ø§Ù„Ø£Ø¯Ù„Ø©',
      steps: [
        {
          title: 'Ø§Ù„Ù…Ø±Ø­Ù„Ø© 1: ØªØµÙ…ÙŠÙ… Ø§Ù„Ø¨Ø­Ø« ÙˆØªØ·ÙˆÙŠØ± Ø§Ù„Ø¨Ø±ÙˆØªÙˆÙƒÙˆÙ„',
          items: ['Ù…Ù†Ù‡Ø¬ÙŠØ© Ù…Ø®ØµØµØ© Ù…ØªÙˆØ§ÙÙ‚Ø© Ù…Ø¹ Ø§Ù„Ù…Ø¬Ø§Ù„ Ø§Ù„Ø¹Ù„Ø§Ø¬ÙŠ', 'Ø§Ù„Ø§Ù…ØªØ«Ø§Ù„ Ø§Ù„ØªÙ†Ø¸ÙŠÙ…ÙŠ (SFDAØŒ DHAØŒ ÙˆØ²Ø§Ø±Ø§Øª Ø§Ù„ØµØ­Ø© Ø§Ù„Ø¥Ù‚Ù„ÙŠÙ…ÙŠØ©)', 'Ø­Ù…Ø§ÙŠØ© Ø§Ù„Ø¨ÙŠØ§Ù†Ø§Øª ÙˆØ§Ù„Ø®ØµÙˆØµÙŠØ©', 'Ù…Ø¹Ø§ÙŠÙŠØ± Ø§Ù„Ø¨Ø­Ø« Ø§Ù„Ø³Ø±ÙŠØ±ÙŠ Ø§Ù„Ø¯ÙˆÙ„ÙŠØ© (ICH-GCP)', 'Ø­Ø³Ø§Ø¨Ø§Øª Ø§Ù„Ù‚ÙˆØ© Ø§Ù„Ø¥Ø­ØµØ§Ø¦ÙŠØ©', 'Ø§Ù„ØªÙƒÙŠÙ Ø§Ù„Ø«Ù‚Ø§ÙÙŠ ÙˆØ§Ù„Ù„ØºÙˆÙŠ'],
        },
        {
          title: 'Ø§Ù„Ù…Ø±Ø­Ù„Ø© 2: ØªÙˆØ¸ÙŠÙ Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ ÙˆØ§Ù„Ù…Ù‡Ù†ÙŠÙŠÙ† Ø§Ù„ØµØ­ÙŠÙŠÙ†',
          subsections: [
            { heading: 'Ø¯ÙˆÙ„ Ø§Ù„Ø®Ù„ÙŠØ¬', items: ['Ù‚ÙˆØ§Ø¦Ù… Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ Ø§Ù„Ù…Ø¹ØªÙ…Ø¯ÙŠÙ† Ù…Ù† Ø§Ù„Ù‡ÙŠØ¦Ø§Øª Ø§Ù„ØµØ­ÙŠØ©', 'Ø´Ø¨ÙƒØ§Øª Ø§Ù„Ø§Ø³ØªØ´Ø§Ø±ÙŠÙŠÙ† ÙÙŠ Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª Ø§Ù„Ø­ÙƒÙˆÙ…ÙŠØ© ÙˆØ§Ù„Ø®Ø§ØµØ©', 'ØªØºØ·ÙŠØ© Ø§Ù„ØªØ®ØµØµØ§Øª Ø§Ù„Ù…ØªØ¹Ø¯Ø¯Ø© (Ø§Ù„Ø£ÙˆØ±Ø§Ù…ØŒ Ø§Ù„Ù‚Ù„Ø¨ØŒ Ø§Ù„ØºØ¯Ø¯ Ø§Ù„ØµÙ…Ø§Ø¡ØŒ Ø¥Ù„Ø®)', 'Ø§Ù„ØªÙ…Ø«ÙŠÙ„ Ø¹Ø¨Ø± Ù…Ø³ØªÙˆÙŠØ§Øª Ø§Ù„Ù…Ø³ØªØ´ÙÙŠØ§Øª (Ø£ÙˆÙ„ÙŠØ©ØŒ Ø«Ø§Ù†ÙˆÙŠØ©ØŒ Ø«Ø§Ù„Ø«ÙŠØ©)'] },
            { heading: 'Ù…ØµØ± ÙˆØ´Ù…Ø§Ù„ Ø£ÙØ±ÙŠÙ‚ÙŠØ§', items: ['Ø´Ø±Ø§ÙƒØ§Øª Ù…Ø¹ Ø§Ù„Ø¬Ù…Ø¹ÙŠØ§Øª Ø§Ù„Ø·Ø¨ÙŠØ©', 'Ø´Ø¨ÙƒØ§Øª Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡ Ø§Ù„Ø¬Ø§Ù…Ø¹ÙŠÙŠÙ†', 'Ø§Ù„ÙˆØµÙˆÙ„ Ù„Ù„Ù‚Ø·Ø§Ø¹ÙŠÙ† Ø§Ù„Ø¹Ø§Ù… ÙˆØ§Ù„Ø®Ø§Øµ'] },
          ],
        },
        {
          title: 'Ø§Ù„Ù…Ø±Ø­Ù„Ø© 3: Ø¬Ù…Ø¹ Ø§Ù„Ø¨ÙŠØ§Ù†Ø§Øª ÙˆØ¶Ù…Ø§Ù† Ø§Ù„Ø¬ÙˆØ¯Ø©',
          items: ['Ù†Ø´Ø± Ø§Ù„Ø§Ø³ØªØ¨ÙŠØ§Ù†Ø§Øª Ù…ØªØ¹Ø¯Ø¯Ø© Ø§Ù„Ù„ØºØ§Øª (Ø§Ù„Ø¹Ø±Ø¨ÙŠØ©ØŒ Ø§Ù„Ø¥Ù†Ø¬Ù„ÙŠØ²ÙŠØ©ØŒ Ø§Ù„ÙØ§Ø±Ø³ÙŠØ©)', 'Ø§Ù„ØªØ­Ù‚Ù‚ Ù…Ù† Ø§Ù„Ø¨ÙŠØ§Ù†Ø§Øª ÙÙŠ Ø§Ù„ÙˆÙ‚Øª Ø§Ù„ÙØ¹Ù„ÙŠ', 'Ø¨Ø±ÙˆØªÙˆÙƒÙˆÙ„Ø§Øª Ø§Ù„ØªØ­Ù‚Ù‚ Ù…Ù† Ù‡ÙˆÙŠØ© Ø§Ù„Ø£Ø·Ø¨Ø§Ø¡', 'Ù…Ø±Ø§Ù‚Ø¨Ø© Ø§Ù„Ø§Ù…ØªØ«Ø§Ù„ Ù„Ù„Ø®ØµÙˆØµÙŠØ© ÙˆØ­Ù…Ø§ÙŠØ© Ø§Ù„Ø¨ÙŠØ§Ù†Ø§Øª', 'Ø§Ù„ØªØ´ÙÙŠØ± Ø§Ù„Ø¢Ù…Ù† Ù„Ù„Ø¨ÙŠØ§Ù†Ø§Øª ÙˆØ§Ù„ØªØ®Ø²ÙŠÙ†', 'ÙØ±ÙŠÙ‚ Ø¨Ø­Ø« Ø«Ù†Ø§Ø¦ÙŠ Ø§Ù„Ù„ØºØ© (Ø¹Ø±Ø¨ÙŠ-Ø¥Ù†Ø¬Ù„ÙŠØ²ÙŠ)'],
        },
        {
          title: 'Ø§Ù„Ù…Ø±Ø­Ù„Ø© 4: Ø§Ù„ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ù…ØªÙ‚Ø¯Ù… ÙˆØªÙˆÙ„ÙŠØ¯ Ø§Ù„Ø±Ø¤Ù‰',
          subsections: [
            { heading: 'Ø§Ù„ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ø¥Ø­ØµØ§Ø¦ÙŠ', items: ['Ù†Ù…Ø°Ø¬Ø© Ø§Ù„Ø§Ù†Ø­Ø¯Ø§Ø± ÙˆØ§Ù„ØªØ­Ù„ÙŠÙ„Ø§Øª Ø§Ù„ØªÙ†Ø¨Ø¤ÙŠØ©', 'ØªÙ‚Ø³ÙŠÙ… Ø§Ù„Ø³ÙˆÙ‚ ÙˆØªØ­Ù„ÙŠÙ„ Ø§Ù„Ù…Ø¬Ù…ÙˆØ¹Ø§Øª', 'Ø§Ù„ØªØ±Ù…ÙŠØ² Ø§Ù„Ù…ÙˆØ¶ÙˆØ¹ÙŠ Ù„Ù„Ø¨ÙŠØ§Ù†Ø§Øª Ø§Ù„Ù†ÙˆØ¹ÙŠØ©', 'Ø§Ù„ØªØ­Ù„ÙŠÙ„ Ø§Ù„Ù…Ù‚Ø§Ø±Ù† Ø¹Ø¨Ø± Ø§Ù„Ø¨Ù„Ø¯Ø§Ù†'] },
            { heading: 'ØªØ­Ù„ÙŠÙ„Ø§Øª Ø®Ø§ØµØ© Ø¨Ø§Ù„Ù…Ù†Ø·Ù‚Ø©', items: ['Ø±Ø³Ù… Ø®Ø±Ø§Ø¦Ø· Ù…Ø³Ø§Ø±Ø§Øª Ø§Ù„Ø¹Ù„Ø§Ø¬ Ø§Ù„Ø¥Ù‚Ù„ÙŠÙ…ÙŠØ©', 'Ø§Ù‚ØªØµØ§Ø¯ÙŠØ§Øª Ø§Ù„ØµØ­Ø© ÙˆØ£Ø¨Ø­Ø§Ø« Ø§Ù„Ù†ØªØ§Ø¦Ø¬ (HEOR)', 'Ù†Ù…Ø°Ø¬Ø© ÙØ¹Ø§Ù„ÙŠØ© Ø§Ù„ØªÙƒÙ„ÙØ©', 'ØªØ­Ù„ÙŠÙ„ Ù…Ø´Ù‡Ø¯ Ø§Ù„Ø¯ÙØ¹ ÙˆØ§Ù„Ø³Ø¯Ø§Ø¯'] },
          ],
        },
        {
          title: 'Ø§Ù„Ù…Ø±Ø­Ù„Ø© 5: Ø§Ù„ØªÙ‚Ø§Ø±ÙŠØ± Ø§Ù„Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ© ÙˆØ§Ù„ØªÙˆØµÙŠØ§Øª',
          subsections: [
            { heading: 'Ø§Ù„Ù…Ø®Ø±Ø¬Ø§Øª', items: ['Ù„ÙˆØ­Ø§Øª Ø§Ù„Ù…Ø¹Ù„ÙˆÙ…Ø§Øª Ø§Ù„ØªÙ†ÙÙŠØ°ÙŠØ© (Ø¹Ø±Ø¨ÙŠ-Ø¥Ù†Ø¬Ù„ÙŠØ²ÙŠ)', 'ØªÙˆØµÙŠØ§Øª Ø§Ø³ØªØ±Ø§ØªÙŠØ¬ÙŠØ© Ù„Ù„ÙˆØµÙˆÙ„ Ù„Ù„Ø³ÙˆÙ‚', 'Ø±Ø¤Ù‰ Ø§Ù„Ù…Ø´Ù‡Ø¯ Ø§Ù„ØªÙ†Ø¸ÙŠÙ…ÙŠ Ø§Ù„Ø¥Ù‚Ù„ÙŠÙ…ÙŠ', 'ØªÙ‚ÙŠÙŠÙ…Ø§Øª ÙØ±Øµ Ø§Ù„Ø³ÙˆÙ‚', 'Ø°ÙƒØ§Ø¡ Ø¯ÙˆØ§Ø¦ÙŠ Ù‚Ø§Ø¨Ù„ Ù„Ù„ØªÙ†ÙÙŠØ°', 'Ø¯Ø¹Ù… Ø§Ù„ØªÙ‚Ø¯ÙŠÙ…Ø§Øª Ø§Ù„ØªÙ†Ø¸ÙŠÙ…ÙŠØ©'] },
          ],
        },
      ],
    },
  },
} as const;

export type TranslationKey = typeof translations['en'];
